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Sommario
La presente tesi e` suddivisa in quattro capitoli. Il Capitolo 1 e` di carattere introduttivo.
Nel Capitolo 2 viene trattata la sintesi e la caratterizzazione strutturale dei complessi
di CuII, NiII e ZnII con il legante N,N’-Bis-5-(trietil ammonio metil salicilidene)-1,2-
fenilendiammina. Inoltre, vengono riportati e confrontati i risultati dello studio della
loro interazione con DNA nativo. Viene in particolare mostrato come l’interazione con
DNA aumenti la stabilita` fotochimica del complesso di ZnII. Infine, vengono evidenzi-
ati gli effetti del confinamento in cristalli liquidi sull’interazione del complesso di CuII e
DNA.Nel Capitolo 3 e` riportata la sintesi e la caratterizzazione strutturale dei complessi
di CuII, ZnII e NiII con due leganti 1,2,4-ossadiazolici sostituiti. Viene inoltre riportato
il primo studio sull’attivita` biologica di un complesso di rame(II) con un legante di
questo tipo. I saggi biologici mostrano che, sebbene uno dei due leganti non sia efficace,
il suo complesso di rame riduce la vitalita` di linee cellulari umane di epatoblastoma e
di carcinoma colorettale. I risultati dei saggi biologici trovano riscontro negli studi di
interazione con DNA dello stesso complesso. Infine, nel Capitolo 4 e` riportata la sintesi
e la caratterizzazione strutturale di un legante derivato dal 2,7-diazapirenio e di un suo
metallociclo binucleare di PtII oltre che lo studio, spettroscopico ed elettroforetico, della
loro interazione con DNA nativo. Sono infine riportati risultati di saggi in vitro che di-
mostrano la citotossicita` di tali composti nei confronti di diverse linee cellulari tumorali.

Abstract
This thesis is divided in four chapters. The aim of the work and a general introduction
on the main DNA-drugs binding modes are reported in Chapter 1. In Chapter 2, the
synthesis and structural characterization of CuII, NiII e ZnII complexes of N,N’-Bis-5-
(triethyl ammonium methyl salicylidene)-1,2-phenylenediamine will be described. Fur-
thermore, the results of the investigation of their interaction with native DNA will be
reported and compared. In particular, it will be shown that the interaction with DNA
increases the photochemical stability of the ZnII complex. Finally, the confinement ef-
fects of tetraethylene glycol monododecyl ether liquid crystals on the interaction of the
CuII complex with DNA will be highlighted. The synthesis and structural character-
ization of CuII, ZnII and NiII complexes of two 1,2,4-oxadiazole ligands is presented in
Chapter 3. Moreover, the first study of the biological activity of a copper(II) complex
of 1,2,4-oxadiazole ligands is reported. In this respect, biological assays show that, des-
pite the free ligand is not being effective, its CuII complex reduces the vitality of human
hepatoblastoma and colorectal carcinoma cells in a dose- and time-dependent manner.
The results of the biological assays receive a positive feedback in the DNA binding stud-
ies performed for the same complex. Finally, in Chapter 4, the synthesis and structural
characterization of a 2,7-diazapyrenium derivate and of his binuclear PtII metallacycle
is reported, as well as the spectroscopic and electrophoretic study of their interaction
with native DNA. Finally, in vitro essays are reported that show the cytotoxic effect of
such compounds toward tumor cell lines.
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6 1. Introduction
Life is what happens to you while
you’re busy making other plans.
J. Lennon, 1980
1.1 Introduction
The argument of this thesis is the synthesis and characterization of metal complexesand the study of their interaction with native deoxyribonucleic acid (DNA). It is
in fact known that DNA is a major target of anticancer drugs and that the most com-
mon clinically used metallo-based anticancer-drugs are today platinum compounds
able to covalently bind to the DNA macromolecule [1]. Nevertheless, platinum anti-
cancer drugs often present serious side-effects. For such reason, nowadays there is a
growing research interest in the study of the reversible interaction of small molecules
with DNA [2–4]. In this context, an interesting aspect of this work is that the metal com-
pounds synthesized interact with DNA through the three principal non-coordinative
modes of binding recognized up to our days: (i) intercalation, (ii) groove binding and
(iii) the recently discovered metallo-supramolecular groove binding [2–4]. A short de-
scription of the three DNA-binding modes is reported below (see Section 1.2). Further-
more, each of the main chapters concerns one of these three DNA-binding modes.
In particular, three DNA-intercalators are considered in Chapter 2. These are CuII,
NiII e ZnII complexes of a Schiff base tetradentate ligand, called H2L2+. In the same
chapter it is shown that DNA intercalation inhibits the photooxidation occurring to
ZnIIL2+ in buffered water solution and that the CuIIL-DNA interaction is deeply affected
by confinement in reverse micelles, mimicking the intracellular environment.
Chapter 3 deals with CuII, NiII e ZnII complexes of two 1,2,4-oxadiazole chelating
ligands (called bipyOXA and pyOXA). It is there shown that [Cu(bipyOXA)2(H2O)2]2+
has the characteristics of a DNA groove binder and that it reduces the vitality of human
hepatoblastoma and colorectal carcinoma cells lines.
Finally, a metallo-supramolecular groove binder, a binuclear PtII 2,7-diazapyrenium
metallacycle, is discussed in Chapter 4. Specifically its effect on the DNA structure as
well as its cytotoxicity against human cancer cell lines are highlighted.
Each of the three chapters is independent from the others and can be read in any
order. Detailed introductions and specific conclusions are reported.
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Figure 1.1: Illustration of the metal compounds whose interaction with DNA was investigated
in this thesis.
Different techniques were used to monitor the DNA-metal complex interactions, for
example: UV-visible absorption and fluorescence spectroscopy, circular and linear di-
chroism and gel electrophoresis. Among these, linear dichroism and polymerase chain
reaction (PCR) electrophoresis will be shortly described in Chapter 2, because of their
peculiarity and novelty.
The results described in the present thesis have been obtained at the University of
Palermo, at the University of La Corun˜a (Spain) and at the University of Birmingham
(UK). In particular, in 2009 I have spent about seven months working with the group of
Professor Jose´ M. Quintela Lopez, University of La Corun˜a. There, I have performed the
synthesis of dinuclear square metallacycles of PtII with the 2,7-diazapyrenium ligand.
Furthermore, I have spent six months with the group of Professor Michael J. Hannon
at the University of Birmingham, in particular exploiting linear dichroism and PCR as
tools to investigate the interaction between metal compounds and native DNA.
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1.2 DNA-drug interactions
The double-helical structure of DNA was first published by Watson and Crick in 1953 [5,
6]. Only few years later, Lerman reported the first studies of the interaction between
small molecules and DNA, demonstrating that acridine dyes intercalate between DNA
base pairs [7] (Figure 1.2). Moreover, Rosenberg et al. indicated cisplatin, a DNA cova-
lent binder, as a highly effective agent in eliminating tumours [8] (Figure 1.2). Since then
the research of small molecules able to interact with DNA has attracted the interests of
many chemists.
Pt
Cl
Cl
H3N
H3N
Cisplatin
Pt
Acridine
N
Figure 1.2: Structure of two important molecules able to interact with DNA: cisplatinum and
acridine.
DNA-binding drugs can be classified according to the type of association with DNA:
covalent binding agents, major- or minor-groove-binders, intercalators, and external
binders (phosphodiester backbone-binders). It is well known that one of the most suc-
cessful anticancer drugs, cisplatin, acts through the formation of coordination bonds
with the N7 nitrogen atoms on two neighbouring guanine DNA bases [1]. In this form,
DNA cannot be processed or correctly repaired by cellular proteins, the cell is therefore
unable to replicate and dies. Despite its success, cisplatin is efficient in only a limited
range of cancers, has lot of severe side-effects and for some other tumours often induces
”resistance” during the treatment [9]. During the past years a number of platinum-
based drugs with less side-effects and improved pharmacological properties were syn-
thesized (Figure 1.3), but the research is now oriented also toward less toxic molecules,
able to interact reversibly with the polynucleotide.
1.2.1 Intercalation
This binding mode involves the insertion of a planar aromatic ring between the base
pairs of DNA, leading to significant pi overlap and for this reason is usually favoured
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Figure 1.3: Structure of Platinum complexes clinically used as anticancer drugs.
by the presence of an extended electron-deficient planar aromatic ligand. Many dif-
ferent compounds have been proven to be DNA-intercalators, for example proflavine,
ethidium bromide and daunomycin (Figure 1.4).
Ethidium Bromide
NH2
H2N
N+
Br-
Proflavine
NH2N NH2
O
OO
OH
OH
C
OH
O
Daunomycin
O
OH
NH3
O
Figure 1.4: Structure of three classic DNA-intercalators.
Intercalating compounds distort the native structure of the DNA double helix. There
is a decrease in the twist angle between the base pairs around the intercalation site,
and the length of the biopolymer is increased. All of these effects are reversible upon
removal of the intercalator at room temperature [10, 11]. The biological effects of the
intercalators are exerted mainly through interference with the recognition and function
of DNA-binding proteins (for example polymerases and topoisomerases), which are
probably responsible of drug-selectivity at the cellular level [12].
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N
N
N
NN
N
N
N N
NH
NH
phi phen dppz terpy
Figure 1.5: Structure of classic ligands used in metallo-intercalators: phi (9,10-
phenanthrenequinone diimine), phen (1,10-phenanthroline), dppz (dipyrido[3,2-a:2’,3’-
c]phenazine) and terpy (2,2’:6’,2”-terpyridine).
Since the DNA phosphate backbone is negatively charged, a suitable method to im-
prove the affinity for DNA of an organic molecule is to incorporate it as a ligand in
a cationic metal complex [2, 13–15]. Moreover, metal compounds usually present in-
teresting features such as luminescence and DNA cleavage properties. The aromatic
ligands shown in Figure 1.5 are among the most used ligands in metal complexes that
are well known as effective non-covalent DNA binders [2, 4]. Barton et al., for example,
found that ruthenium(II) polypyridine octahedral complexes, produce what has become
known as ”light switch effect”: they only emit when are bound to DNA [16]. As an-
other example, the rhodium(II) complex of the phi ligand (see Figure 1.5) was the first
DNA-metallo-intercalator binding complex whose structure was characterized by X-ray
crystallography [2,17]. In the same context, during the first part of my Ph.D. I have con-
cluded the investigation of the DNA interaction with a FeIII complex with the ligand
dppz, which was found to be a strong DNA-intercalator [18]. Such investigation was
the argument of my thesis for the master degree in Chemistry.
Although intercalation mechanism was proposed years ago, its ”appeal” is still un-
touched. For instance, it has been recently reported that human telomeric quadruplex
DNA structure, a potential target of novel anticancer drugs [19, 20], is stabilized by
metal-Salphen complexes that are known intercalators [21, 22]. Even more recently,
Hepes (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) was found to stabilize by
intercalative interaction a Z-Z junction, a potential target of a number of anticancer
drugs during DNA replication [23].
DNA junctions are formed when two or more duplexes come together and exchange
strands. The Z-Z junction is formed at a discontinuity point of the double strand, where
a single nitrogen base is present without its complementary counterpart, producing Z-
DNA double helices. Hepes is inserted in the junction region of the left-handed helix,
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Figure 1.6: Adapted picture of Hepes intercalated in a DNA duplex. Overall structure of a Z-Z
junction. The DNA duplex is shown as a skeletal model. Four Zα protein domains are bound to
the duplex (CG)3A(CG)3 DNA oligonucleotide and shown as ribbon diagrams. The molecular
surface of each chain is shown transparent [23].
which is otherwise resistant to intercalation. The unexpected Hepes intercalation sta-
bilizes the left-handed conformation by restoring base stacking to some extent and
may have deleterious effects for cancer cells resulting in lethal DNA rearrangements.
Moreover, this finding could explain one of the mechanisms through which intercalat-
ing agents exert their anticancer action [23].
1.2.2 Groove-binding
B-DNA has two distinct grooves in the double-helical structure, termed minor and ma-
jor. Proteins and large molecules, for example oligonucleotides, bind DNA preferen-
tially through the major groove, because it is a good receptor in terms of size, flexibil-
ity and possibility to form H-bonding [2, 24, 25]. Small molecules typically bind DNA
through the minor groove, where sequence recognition is limited compared to the major
groove, in large part due to less varied H-bonding patterns and more limited shape vari-
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Figure 1.7: Minor groove binding agents.
ations with sequence. The natural compound distamycin A, synthetic diarylamidines
(such as DAPI and pentamidine) and bis-benzimidazoles (such as Hoechst 33258) are
among the most common groove binders (see Figure 1.7).
Minor groove binders are characterized by a high level of sequence specificity. They
are among the most widely studied class of DNA-binding agents and exhibit several
biological activities. Some of them, for example, have found clinical application in treat-
ing cancers, protozoal diseases, as anti-viral and anti-bacterial agents [26]. DAPI and
Figure 1.8: View of DAPI (orange with transparent surface) binding in the minor groove of
DNA [27].
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pentadimine, two proved DNA groove binders (see Figure 1.7 and Figure 1.8), reached
the clinical trial phase because of their effective antiparasitic activity, especially against
trypanosomes [26,28]. DAPI was shown to inhibit DNA and RNA polymerase and was
found to bind specifically to AT-rich regions of double-stranded DNA [26, 29].
Recently, a series of 1,3,4-oxadiazoles, an important class of heterocyclic compounds
with a broad spectrum of biological activities, were found to induce apoptosis in cul-
tured breast cancer cells [30]. Interestingly, several metal complexes are DNA-groove
binders. For example, PtII complexes of substituted 1,2,4-oxadiazole derivatives, that
are DNA-groove binders, have shown antitumor activity towards human ovarian can-
cer cell lines [31].
1.2.3 Metallo-supramolecular groove binding
Chemistry-biology interfaced research groups have been in the last years interested in
finding novel types of drug-DNA recognition modes. Molecules able to interact with B-
DNA via conventional binding processes, were found to recognize and stabilize triplex
and quadruplex DNA structures as well [2].
Cationic benzopyridoindole ligand BePI and the analogous BfPQ and BQQ, for in-
stance (see Figure 1.9), were found to have a strong preference for triplex over duplex
DNA [2, 32, 33].
N
N
HMe
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NH3
O Me
N
N
N
O
NH
NH3
Me
N
N
N
O
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NH3
Me
BePI BfPQ BQQ
Figure 1.9: Triplex-binding intercalators. BePI (benzo[e]pyridoindole derivative), BfPQ
(benzo[f]pyrido[3,4-b]quinoxaline) and BQQ (benzo[f]quino[3,4-b]quinoxaline) [32, 33].
Even more interesting is the possibility to stabilize DNA junction structures through
synthetic agents specifically designed. Cardin et al. have recently described the crystal
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structure of two bis-acridine intercalators combined with eight oligonucleotides, simu-
lating a 4-way junction (the so called Holliday junction) [2, 34].
The role of triplex and quadruplex junction DNA structures in cells is not yet clear
and the design of specific chemical probes which recognize only one of the many pos-
sible structures could help to this aim. In this context, supramolecular assemblies, such
as those constituted by metal complexes fitting the size of the DNA major groove, have
been recently considered. The self-assembly approach, and in particular the use of
metal ions to control it, has led to the synthesis of topologically novel molecular struc-
tures, including, knots, grids, boxes and cylinders [35–39]. These so called metallo-
supramolecular agents, bigger than the usual DNA binders, can mimic the dimensions
of protein DNA recognition motifs. Hannon et al., for example, have designed an iron(II)
tetracationic triple-stranded cylinder (see Figure 1.10) with dimensions similar to those
of the alpha-helical DNA recognition unit of zinc fingers proteins. It has been demon-
strated, in particular by X-ray crystallography, that this cylindrical molecule binds in
the major groove of DNA duplex and that it fits in the heart of a DNA 3-way junction,
the first completely new way of DNA recognition in the last 40 years [2, 40].
NN
N N
Fe2+
3
Figure 1.10: The metallo-supramolecular iron cylinder synthesized by Hannon et al. [2, 40].
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But the fool on the hill sees the sun
going down, and the eyes in his head
see the world spinning round.
Lennon/McCartney, 1967
2.1 Introduction
The condensation of an amine with an aldehyde, forming a Schiff base, is one ofthe oldest reactions in chemistry [41, 42]. The condensation of a salicylaldehyde
with 1,2-diaminoethane gives what is called “Salen”, an acronym widely used to de-
note a family of Schiff base compounds having a structure derived from N,N’-bis (sali-
cylidene) ethylenediamine (see Figure 2.1). In particular, when 1,2-phenylendiamine
derivatives instead of the 1,2-diaminoethane are used, the final products are generally
called “Salphen” ligands.
HOOH
N N
HOOH
N N
H2Salen H2Salphen
Figure 2.1: Geometries of H2Salen (N,N’-Bis-salycilidene-ethylenediamine) and of H2Salphen
(N,N’-Bis-salicylidene-1,2-phenylenediamine) ligands
Schiff bases are among the most popular nitrogen donor ligands. In fact, because of
its Lewis basicity, the imino nitrogen is well suited to form coordination bonds with
metal ions [43, 44]. When the two hydroxy groups are deprotonated, these ligands
present four coordination sites, two oxygens and two nitrogens, in an almost square
planar array. For this reason, they are suitable for the equatorial coordination of trans-
ition metals, leaving two axial sites open for the potential coordination of ancillary lig-
ands. Salen and Salphen ligands are easy to prepare, inexpensive and generally stable.
The salicylidene imino group of the isolated ligand may undergo acid-catalyzed hy-
drolysis, reverting to the corresponding salicylaldehyde and diamine in the presence of
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water [44]. However, Salen- and Salphen-metal complexes are even more stable and can
be used in aqueous media without undergoing hydrolysis. In 1889 Combes prepared
the first Salen-type ligand and its Cu complex [45]. Since then, Salen derivatives and
their metal complexes have been extensively used in transition-metal chemistry for a
large variety of applications, especially in catalysis [42, 44, 46]. In homogeneous and
heterogeneous catalysis they have been used in numerous organic conversions includ-
ing the epoxidation of olefins and asymmetric ring opening of epoxide [47].
In particular, metal complexes of the ligand shown in Figure 2.2 have been success-
fully applied to a broad range of industrially important asymmetric reactions. The MnIII
complex of this ligand, for example, is known as “Jacobsen’s catalyst” and is currently
the most efficient catalyst available for the enantioselective epoxidation of unfunction-
alized olefins [46, 48].
HOOH
N N
t-Bu
t-But-Bu
t-Bu
Figure 2.2: The Salen-type ligand used for the “Jacobsen’s catalyst”
Salen and Salphen complexes have been recently used as molecular building blocks
in material science. For example, they have been incorporated into a wide variety of
structures and devices such as sensors, multimetallic systems useful for cooperative
catalysis and molecular templates for organic and inorganic synthesis [49].
Moreover, several Salen metal complexes have found biomedical applications, for
instance as potent anti-inflammatory or anti-viral drugs, as models for superoxide dis-
mutase and as markers for several pathological conditions including ovarian cancer [42,
50, 51]. For example, a FeIII-Salphen complex is a potent growth-suppressing agent in
vitro for ovarian cancer cell lines, with a potential therapeutic use in the treatment of
such tumors in vivo [51, 52]. Mn-Salphen (EUK178) and different Mn-Salen derivat-
ives display cytoprotective features in fibroblast cultures via hydrogen peroxide scav-
enging [51, 53].
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Figure 2.3: A Salphen-type complex (red coloured, in the middle) proposed by Vilar et. al [19,
20], that produce quadruplex DNA stabilization.
Among the various mechanisms through which Salen metal complexes carry out
their action in bioenvironments, of utmost importance is their direct interaction with
DNA. Salen, Salphen and their functionalized water-soluble ligands coordinate trans-
ition metal atoms via a square planar N2O2 system and are characterized by an extended
nearly planar area. These properties make Salphen metal complexes potential candid-
ates as DNA intercalators, while Salen metal complexes, lacking the aromatic phenyl
moiety, are usually external DNA binders [54]. As a matter of fact, several DNA bind-
ing studies of metal complexes of Salen-type ligands have been reported in the liter-
ature [19, 55–60]. For example, it has been recently reported that some metal-Salphen
complexes are able to stabilize human telomeric quadruplex DNA structures (see Fig-
ure 2.3), potential targets of novel anticancer drugs [19, 20].
In this context, the interaction between native DNA and CuII and ZnII complexes of
N,N’-Bis-5-(triethyl ammonium methyl salicylidene)-1,2-phenylenediamine (H2L2+, see
Figure 2.4) has been recently investigated [21]. The results obtained collectively show
that ZnL2+ and CuL2+ strongly interact with native DNA, by a combined electrostatic
and intercalative mechanism and that CuL2+ is a stronger DNA binder than ZnL2+. In
the first pargraph (Section 2.2) of the present chapter further insights into this interac-
tion are presented, as well as that between DNA and the nickel(II) complex of the same
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Figure 2.4: Structure of the ML2+ complex (M = Cu, Ni, Zn, H2L2+ = N,N’-Bis-5-(triethyl am-
monium methyl salicylidene)-1,2-phenylenediamine).
The structural characterization of the three complexes and the spectroscopic study
of their interaction with the DNA macromolecule are the core of the first part of this
chapter. For what concerns the study of the DNA-metal complex interaction, the fol-
lowing spectroscopic techniques were mainly used as investigation tools: variable tem-
perature UV-visible absorption, fluorescence emission, circular and linear dichroism.
Moreover, the effect of the complexes on the DNA processing was further investigated
by performing in vitro experiments as gel-electrophoresis and polymerase chain reaction
(PCR) assays. On the basis of all these techniques, which afford an indirect and comple-
mentary evidence of the interaction occurrence, a DNA-intercalation mechanism was
confirmed for the three metal complexes, with a decreasing interaction strength in the
order: NiL2+ > CuL2+ > ZnL2+.
Furthermore, a detailed investigation of the photophysical and photochemical prop-
erties of ZnL2+, due to its exposition to tungsten lamp light and of how these proper-
ties are influenced by its interaction with DNA is presented in the second paragraph
(Section 2.3). Fluorescence spectroscopy measurements were mainly exploited for this
purpose. Moreover, quantum chemical calculations were performed to support the hy-
pothesis that the effect of the photoexposition is to partially oxidize ZnL2+ to ZnL4+ [61].
Finally, the study of the interaction of the CuL2+ with DNA in a micro-heterogeneous
system, able to segregate the biomolecule in a nanoscopic domain made by tetraethyl-
ene glycol monododecyl ether liquid crystals, is reported in the third paragraph (Sec-
tion 2.4). Such inverse micellar system was intended as a ”biomimetic” model of the
intra-cellular environment [62].
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2.2 The interaction of DNA with NiL2+, CuL2+ and ZnL2+
The interaction between native DNA and CuL2+ and ZnL2+ cationic complexes in aqueous
solution has been previously described [21]. Here the investigation is extended to the
NiL2+ complex, with the aim to evaluate the role of the metal atom on the DNA binding
properties of NiII, CuII and ZnII complexes of the same Schiff base ligand [22]. In details,
the UV-visible absorption, circular dichroism and fluorescence spectroscopic techniques
have been used to investigate NiL-DNA solutions. Furthermore, flow linear dichroism
titrations of DNA aqueous solutions in the presence of increasing amounts of the NiL2+,
CuL2+ and ZnL2+ complexes are reported. Finally, their effect on the DNA processing
was tested through in-vitro experiments, such as gel-electrophoresis and polymerase
chain reaction (PCR) assays.
2.2.1 Structural characterization of NiL2+, CuL2+ and ZnL2+
NiL2+, CuL2+ and ZnL2+ were characterized by elemental analysis, ESI mass exper-
iments and 2D-NMR, including COSY, HSQC and HMBC spectra (see Experimental,
Section 2.5 and Appendix A). The NMR spectra of the paramagnetic CuL2+ complex
were not reported, while its structure was characterized in the solid state by X-ray crys-
tallography. In fact, suitable crystals for X-ray diffraction analysis were obtained only
for the copper complex (see below and Appendix B). The NiL2+ crystals were too small
while it was not possible to crystallize the ZnII complex. Considering that NiII has a
d8 electronic configuration, the square planar N2O2 coordination around the Ni atom
can be also inferred on the basis of the diamagnetic nature of the compound, typical of
planar nickel compounds. According to the literature, the diamagnetism of Ni-Salen is
also maintained in solutions of coordinating and non-coordinating solvents [63]. This
evidence is confirmed by the NMR spectra obtained. The 1H-NMR of NiL2+ and its
labelling are shown in Figure 2.5.
Concerning the coordination geometry of ZnL2+, a comparison between calculated
and experimental electronic spectra (see Section 2.3) suggests the presence of an ap-
ical water molecule coordinating the metal atom, creating a pentacoordinated aquo-
complex, in agreement with the structure of ZnSalphen complexes reported in the liter-
ature [63].
The crystal structure of CuL2+ (see Figures 2.6 and B.1) has been obtained from
single crystal X-ray diffraction data and confirms the expected molecular conformation
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Figure 2.5: 1H NMR (500 MHz, DMSO) of the NiL2+ complex. Further NMR spectra of NiL2+
and ZnL2+ are reported in Appendix A.
as shown in Figure 2.4. The structure contains two crystallographically independent
copper complexes which display the same molecular configuration and similar geomet-
ries that fall within the normal ranges for these types of species, although the poor data
quality does affect the accuracy with which geometric parameters can be determined
from this structure. As expected, the structure contains two perchlorate ions per copper
complex as well as benzene, nitromethane and highly disordered water molecules (see
Experimental Section 2.5). The two crystallographically independent copper complexes
form columns through intermolecular pi-pi stacking interactions with an interplanar dis-
tance of approximately 3.3 A˚(see Figure B.2). In one of the unique copper complexes
(see Figure B.1) three methyl groups, C(124)/C(24’), C(126)/C(26’) and C(128)/C(28’)
are disordered over two positions each, at percentage occupancy ratios of 71 (4):29 (4),
56 (4):44 (4) and 60:40 respectively. Most of the water molecules are highly disordered
and it was not possible to refine them all anisotropically or locate all the hydrogen atoms
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Figure 2.6: Ortep view of one of the two crystallographically independent copper complexes
of CuL2+ with ellipsoids drawn at the 50% probability level. The perchlorate ions, benzene,
nitromethane and water molecules and hydrogen atoms have been omitted for clarity. The color
labelling scheme is as follows: carbon (black), copper (orange), nitrogen (blue) and oxygen (red).
belonging to them in the electron density. As a result of this it was not possible to list
all the hydrogen bonding. All hydrogen atoms not belonging to water molecules were
added at calculated positions and refined by use of a riding model with isotropic dis-
placement parameters based on the equivalent isotropic displacement parameter (Ueq)
of the parent atom. The hydrogen atoms belonging to water molecule H(81A)-O(801)-
H(81B) were located in the electron density and their positions refined subject to O-H
(0.88 (2) A˚) and H-H (1.41 (4) A˚) bond distance restraints.
2.2.2 UV-visible absorption of NiL-DNA solutions
The UV-vis absorption spectrum of NiL2+ in aqueous solution (black solid line in Fig-
ure 2.7) shows an intense band at about 261 nm and a weaker band in the range 330–400
nm, attributable to a metal perturbed infra–ligand electronic transition [21]. Such spec-
trum is significantly modified by the addition of increasing amounts of calf thymus
DNA (ct-DNA). In details, the absorption band of NiL2+ at 352 nm (see Figure 2.7) is
red shifted by about 10 nm and shows hypochromism of about 40% at [DNA]:[NiL2+]
molar ratio equal to 10. Furthermore, the intensity of the absorption band at 260 nm
is lowered by the addition of DNA up to [DNA]:[NiL2+] molar ratio of 0.75 and in-
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Figure 2.7: Uv-vis of 20 µM NiL2+ (1 mM Tris-HCl buffer) in the presence of increasing concen-
tration of ct-DNA, in the range [DNA]:[NiL2+] = 0.5:1 - 10:1 as shown.
creases at higher molar ratios. These evidences collectively suggest that NiII complex
is a DNA intercalator [54, 64]. To determine the intrinsic binding constant (Kb) and the
stoichiometry of the NiL2+–DNA system, the quantity y (see Eq. 2.1) at 352 nm has
been plotted, in Figure 2.8, as a function of the molar concentration of DNA. The quant-
ity y contains the molar extinction coefficients of NiL2+, free ("f ) and bound to DNA
("b) and of the solution containing both free and bound NiL2+ ("a). In details, "f is de-
termined by a calibration curve of the isolated metal complexes in aqueous solution,
following the Beer-Lambert law; "b is found out from the plateau of the DNA titration
(Figure 2.8), where addition of DNA did not result in further changes in the absorption
spectrum [21]; finally, "a is obtained as the ratio between the measured absorbance and
the NiL2+ molar concentration [21]. The values of the intrinsic binding constant (Kb)
and of the binding size in base pairs (s) of the NiL2+ complex were obtained by using
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Figure 2.8: Spectrophotometric titration of NiL2+, at 352 nm, with ct-DNA in aqueous solution;
[NiL2+] = 20 µM, [DNA] = 0 - 200 µM. The solid line is the fit of the experimental data by Eq. 2.1.
Eqs. (2.1) and (2.2) [21, 65, 66]:
y =
"a − "f
"b − "f
=
b−
√
(b2 ·
2K2bCt[DNA]
s
)
2KbCt
(2.1)
b = 1 +KbCt +
Kb[DNA]
2s
(2.2)
where Ct is the total concentration of the metal complex. It is known that the model
leading to Eqs. (2.1), (2.2), proposed by Carter et al. [65], is valid in the assumption of
a non–cooperative and non–specific binding to DNA. The Kb and s values obtained by
non linear fits of the experimental data by Eqs. (2.1), (2.2) were Kb = (4.2 ± 0.4)×106 M−1
and s = 1.01±0.04. These results confirm that the metal complex strongly interacts with
DNA. In particular, NiL2+ shows an interaction stoichiometry of approximately 1 mol of
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DNA base pairs per 1 mol of metal complex. Interestingly, the binding of NiL2+ to DNA
is slightly higher than that relative to the CuL-DNA system and more than 10 times
higher than that relative to the ZnL-DNA system (see Table 2.1). These comparisons
suggest that the binding capability to the DNA backbone is critically influenced by the
specific electronic and geometrical structures of similar complexes of the same ligand
differing only in the nature of the metal atom.
Table 2.1: Comparison of Kb and s values of ML-DNA systems
NiL-DNA CuL-DNA [21] ZnL-DNA [21]
Kb (M−1) (4.2 ± 0.4)×106 (1.28 ± 0.05)×106 (7.35 ± 0.01)×104
s 1.01 ± 0.04 0.73 ± 0.01 0.69 ± 0.01
2.2.3 DNA Thermal Denaturation Analysis of NiL-DNA solutions
The thermal behavior of DNA offers some information about its binding affinity toward
small molecules. The melting temperature (Tm) of DNA, which is defined as the temper-
ature at which half of the double-stranded DNA is dissociated into single strands [67],
is strictly related to the stability of the macromolecule and may be altered by the inter-
action with chemicals. For example, it has been reported [68, 69] that the stacking in-
teractions, typical of intercalation processes, produce a stabilization of the DNA double
helix followed by a considerable increase in the melting temperature. Thermal denat-
uration profiles of ct-DNA solutions, in the presence of increasing amounts of NiL2+,
were obtained by plotting the absorbance at 258 nm as a function of temperature (see
Figure 2.9 and Table 2.2). It can be seen that Tm of ct-DNA (46± 1◦C) increases of about
33 and 36 ◦C, at [DNA]:[NiL2+] molar ratios 10:1 and 5:1. These results are consist-
ent with the hypothesis of DNA-intercalation of the metal complex leading to a more
compact structural arrangement of the DNA double helix. Furthermore, the presence
of a positive charge on the NiL2+ complex should furnish further contributions to the
stabilization of the double helix as a consequence of the partial neutralization of the
negatively charged phosphate groups. Finally, as highlighted by the data collected in
Table 2.2, the increase of the DNA melting temperature (∆Tm) caused by addition of
NiL2+ to the DNA solution, compared to that caused by CuL2+ and ZnL2+ [21], leads to
the same conclusions drawn by comparing the binding constants of three parent com-
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Figure 2.9: Thermal denaturation profiles of ct-DNA in the presence of increasing amounts of
NiL2+, in 1 mM Tris-HCl buffer; [DNA] = 100 µM; [NiL2+] = 0 (squares, Tm = 46 ± 1 ◦C), 10 µM
(circles, Tm = 79 ± 1 ◦C), 20 µM (triangles, Tm = 82 ± 1 ◦C).
Table 2.2: Comparison of ∆Tm values of ML-DNA systems
[DNA]:[ML2+] NiL-DNA CuL-DNA [21] ZnL-DNA [21]
(◦C) (◦C) (◦C)
10:1 33 21 14
5:1 36 37 17
plexes. In fact, at [DNA]:[ML2+] = 10:1 the ∆Tm decreases in the order: NiL2+ > CuL2+
> ZnL2+. On the other hand, NiL2+ and CuL2+ at [DNA]:[ML2+] = 5:1 induce the same
∆Tm.
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2.2.4 Circular Dichroism of NiL-DNA solutions
Circular dichroism (CD) refers to the differential absorption of the two circularly polar-
ized components, one rotating counter-clockwise (left handed) and the other clockwise
(right handed) of a plane polarized light. The idea behind CD is that the interaction
between left and right handed photons and a chiral molecule will be different, thus
only chiral molecules are able to produce a CD signal [70].
Figure 2.10: Circular dichroism spectra of 40 µM ct-DNA in the presence of increasing amounts
of NiL2+ in 1.0 mM Tris-HCl, in the range [DNA]:[NiL2+] = 10:1 - 1.4:1 as shown.
CD spectra of ct-DNA were recorded in the presence of increasing amounts of NiL2+,
up to [DNA]:[NiL2+] molar ratios of approximately 1.4 (see Figure 2.10 and inset). Due
to its right-handed helicity, the CD of native DNA (black solid line in Figure 2.10) exhib-
its a positive band centered at 275 nm and a negative band centered at 245 nm. Similarly
to what observed for the CuL-DNA and ZnL-DNA systems [21], this typical spectrum
is modified by the addition of increasing amounts of NiL2+ suggesting the occurrence
of DNA structural modifications following the metal complex-DNA interaction. In par-
ticular, a decrease of the intensity and a blue shift of the positive CD band of DNA are
observed and a weak induced CD negative band appears in the range 350-400 nm. The
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latter finding can be interpreted by considering that the NiL2+ moiety supplies a further
chromophore appended to the chiral backbone of DNA [71].
Noteworthy, the intensity of the positive band of DNA monotonously decreases with
the addition of metal complex and becomes negative at NiL2+ concentrations higher
than 14 µM, corresponding to a [DNA]/[NiL2+] molar ratio equal to 2.8. Moreover, the
intensity and shape of CD spectrum in the presence of [NiL2+]≥ 20 µM is dramatically
different from that of native DNA (see inset in Figure 2.10) and it is characterized by
two extremely intense negative and positive bands at about 260 and 290 nm, which can
be attributed to the presence of supramolecular DNA aggregates in solution [72].
To analyze the spectral changes induced by the addition of NiL2+, the molar ellipt-
icity (a) and the UV absorbance (b) at 248 nm as a function of the NiL2+ concentration
are reported (see Figure 2.11). The values of the absorbance follow a linear trend with
Figure 2.11: Molar ellipticity (a) and UV absorbance (b), both at 248 nm, of NiL-DNA aqueous
solutions in the presence of increasing amounts of NiL2+; [DNA] = 40 µM, [NiL2+] =0-28 µM.
the metal complex concentration, confirming that the Lambert-Beer law is fulfilled in
the investigated concentration range. On the other hand, the molar ellipticity can be
described by two trends that intersect at about 18 µM, corresponding to approximately
1 NiL2+ per 2 DNA monomeric units, that roughly coincides with the stoichiometry
value obtained by both fluorescence (see below) and UV-vis measurements. From these
findings it can be argued that: i) a tight binding exists between the metal complexes
and DNA; ii) the conformational changes of the DNA double helix are dramatic when
the complex concentration is higher than 14 µM, probably due to the formation of DNA
aggregates [72].
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2.2.5 Ethidium bromide displacement assay of NiL-DNA solutions
It is known that ct-DNA does not give fluorescence, while the emission intensity is
greatly enhanced in the presence of ethidium bromide (EB). EB is also weakly fluores-
cent, but the EB-DNA complex is remarkably more fluorescent giving an emission band
at about 600 nm, as a consequence of the intercalation of EB between adjacent DNA base
pairs [73]. The enhancement of the EB fluorescence is due to the inhibition of the amino
Figure 2.12: Fluorescence spectra of the EB-DNA complex in the presence of increasing amounts
of NiL2+. [EB] = 4 µM, [DNA] = 25 µM, range [DNA]:[NiL2+] = 40:1 - 2:1 as shown. Inset:
fluorescence intensity at 600 nm vs. the NiL2+ molar concentration.
proton transfer to the solvent occurring when EB is segregated within the DNA mo-
lecule. This phenomenon is accompanied by an increase of the EB excited state lifetime.
In particular, several thorough investigations have established that a model based on tri-
exponential function is the most appropriate to describe the fluorescence decay kinetics
of EB in DNA solutions [74–76]. Such model involves that two kinds of EB molecules
with different lifetimes, bound with low and high affinity to DNA sites, respectively,
coexist with free EB in DNA aqueous solutions. Then, it follows that steady state and
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Figure 2.13: Representative decays of the investigated systems. [EB] = 4 µM, [DNA] = 25 µM;
[DNA]:[NiL2+] = 0 (a); 10:1 (b); 5:1 (c); 2.5:1 (d). In each panel, the inset shows the residuals.
time-resolved fluorescence spectra of EB in DNA aqueous solutions in the presence of
various amounts of competitive non-fluorescent species could be useful to study the af-
finity of the added molecule to DNA [77]. The emission spectra of the EB-DNA complex
in Tris-HCl 1 mM, in the presence of increasing amounts of the non-fluorescent NiL2+,
are shown in Figure 2.12. It can be noted that the intensity of the fluorescence spectrum
of the EB-DNA complex is lowered by the addition of increasing amounts of the com-
plex. In particular, by plotting the fluorescence intensity at 600 nm vs. the NiL2+ molar
concentration (see the inset in Figure 2.12), an initial steep decrease of the signal is no-
ticed in the range 0-4 µM, trending to level off at higher NiL2+ concentration. Taking
into account that the EB concentration is 4 µM, this behavior is consistent with the hy-
pothesis that NiL2+ competes effectively with EB for the same DNA binding sites with
a displacement stoichiometry of approximately 1 mole of metal complex per 1 mole of
EB.
Concerning the time-resolved fluorescence experiments, according to literature, the
spectrum of EB in aqueous solution of ct-DNA can be consistently described in terms
of three exponential decay functions [74–76]. Moreover, as highlighted in Figure 2.13,
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Table 2.3: Fitting parameters resulting from three exponential function analysis of the fluor-
escence decay profiles of NiL2+/EB/DNA aqueous solutions at various [DNA]:[NiL2+] molar
ratios and fixed EB (4 µM) and DNA (25 µM) concentrations
[DNA]:[NiL2+]
τ 1 A1 τ 2 A2 τ 3 A3
(ns) (%) (ns) (%) (ns) (%)
ct-DNA 1.6 26.1 9.1 43.1 20.5 30.8
40:1 1.3 33.9 8.0 35.6 20.0 30.5
20:1 1.4 44.6 7.3 30.4 19.4 25.0
10:1 1.3 57.8 6.0 26.7 19.9 15.6
6.6:1 1.4 69.0 5.5 20.2 20.0 10.7
5:1 1.3 74.7 4.2 19.2 20.8 6.0
4:1 1.3 83.9 4.6 12.9 19.8 3.2
3.3:1 1.3 81.2 3.5 16.2 20.8 2.6
3:1 1.2 83.6 3.3 14.6 20.8 1.8
2.5:1 1.3 87.6 3.3 10.6 20.8 1.8
2:1 1.2 88.9 3.3 9.2 20.4 1.9
Figure 2.14: 1/R dependence of the (a) lifetimes (τ1, squares; τ2, circles; τ3, triangles) and of
the (b) component amplitude (A1, squares; A2, circles; A3, triangles) of the three EB species in
NiL2+/EB/DNA aqueous solutions.
also the spectra of EB in aqueous solution of ct-DNA containing increasing amounts of
NiL2+ are well-described by three exponential decay functions. The fitting parameters
(component amplitude, A%; lifetime, τ ) for all the investigated samples are collected in
Table 2.3.
By analyzing the data of Table 2.3 and their 1/R dependence (R = [DNA]:[NiL2+]),
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shown in Figure 2.14, some observations can be made: i) the lifetime of deeply intercal-
ated EB is practically unaffected by an increase of the NiL2+ concentration emphasizing
the nature of this binding site, while that of free EB shows a moderate decrease attrib-
utable to medium induced quenching effects; ii) the lifetime of EB molecules bonded
to low affinity DNA sites decreases smoothly with 1/R emphasizing that these sites
are accessible to species present in the solution able to quench EB; iii) as expected, the
component amplitude of free EB increases with 1/R whereas those of EB bound at low
and high affinity DNA sites decrease. It must be pointed out that the simultaneous de-
crease of the component amplitudes of the two types of bonded EB suggests that NiL2+
competes effectively and with comparable strength for both sites; iv) even at the lower
[DNA]:[NiL2+] values investigated, the component amplitudes of the two kind of bon-
ded EB do not vanish, implying that some changes occur hindering a total exchange
with the NiL2+ species.
2.2.6 Linear Dichroism of ML-DNA solutions (M = Ni, Cu, Zn)
Linear dichroism (LD) has been largely used for studying DNA-drugs interactions and
is defined as the difference in absorption of light linearly polarized parallel and perpen-
dicular to an orientation axis at a given wavelength [70, 78]:
LD(λ) = A‖ − A⊥ (2.3)
Linear dichroism can be used with systems that are either intrinsically oriented or
are oriented during the experiment. In experiments that involve ct-DNA, the long poly-
mer is oriented by the viscous drag caused when a solution flows between narrow walls
(see Figure 2.15) [70,78]. The orientation of the small molecules bound to DNA are then
probed by comparing the absorption of light linearly polarized parallel to and perpen-
dicular to the direction of flow. Small molecules that are unbound or randomly bound
to the polymer will not be oriented and will show no differential absorption. However,
small molecules bound in a specific orientation(s) to the polymer, will themselves be-
come oriented by the flow and the orientation of their spectroscopic transitions can then
be probed [70, 78].
.
Due to the fact that the base pairs are almost perpendicular to the helical axis, B-
DNA exhibits a characteristic negative band between 220 nm and 300 nm (black solid
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Figure 2.15: Schematic diagram of Couette flow cell.
Figure 2.16: LD of 280 µM ct-DNA in 20 mM NaCl and 1 mM cacodylate buffer in the presence
of increasing concentration of NiL2+, in the range [DNA]:[NiL2+] = 100:1 - 4:1 as shown.
line in Figures 2.16, 2.17 and 2.18) caused by pi − pi∗ transitions [70]. Molecules that are
able to interact with the DNA could produce a decrease of the intensity, due for example
to coiling effect, or an increase of the same band, generally caused by intercalation of
aromatic rings between the bases of the DNA (”stiffening”) [70, 78].
In these experiments a ct-DNA solution was injected in the annular gap between
the rotating and the fixed coaxial cylinder of a Couette flow apparatus (Figure 2.15).
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During the spinning process (the rotation gradient was maintained constant over all
the experiment) increasing amounts of the complexes solution were added in order to
obtain different [ct-DNA]:[complex] ratios.
Figure 2.17: LD of 300 µM ct-DNA in 20 mM NaCl and 1 mM cacodylate buffer in the presence
of increasing concentration of CuL2+, in the range [DNA]:[CuL2+] = 100:1 - 3:1 as shown.
The LD spectra of ct-DNA in presence of increasing amounts of NiL2+, CuL2+ and
ZnL2+ are shown in Figures 2.16, 2.17 and 2.18 respectively. The presence of the two
induced LD bands in the metal to ligand charge transfer region (centered at 376 and 455
nm for NiL2+, at 330 and 417 nm for CuL2+ and 330 and 385 nm for ZnL2+), indicates
firstly that there is an interaction between the three metal compounds and the DNA and
that these compounds are oriented in a specific way by the polynucleotide. More inter-
estingly, all the complexes induce an enhancement of the DNA negative band indicating
an intercalative binding mode. This result definitively confirms the DNA-intercalating
nature of the three complexes, obtained by the complementary CD, UV-vis and fluores-
cence measurements [21, 22]. The effect of the NiII compound on the DNA structure is
larger with respect to that of both CuII and ZnII, as can be argued by the shape of the
titration spectra and by the linear trend of the plot in Figure 2.19. In the latter Figure
the differential DNA LD signal at 260 nm (obtained by subtracting from each LD value
at this wavelength the DNA signal at the same wavelength) is reported as a function of
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Figure 2.18: LD of 320 µM of ct-DNA in 20 mM NaCl and 1 mM cacodylate buffer in the presence
of increasing concentration of ZnL2+, in the range [DNA]:[ZnL2+] = 100:1 - 4:1 as shown.
the NiL2+, CuL2+ and ZnL2+ concentration. The differential LD decreases with a higher
slope for the NiII compound. This latter finding is also in good agreement with the res-
ults previously obtained, where a bigger binding constant (Kb) for the NiII compound
was obtained (see Table 2.1) [22]. As a matter of fact, NiII Salphen compounds present
a more planar coordination with respect to CuII and ZnII complexes. In details, while it
is well know that the stability of the square planar NiII site prevents coordination of the
NiII ion with moderately strong axial ligands [63, 79], there may be an equilibrium with
axial hydration of the copper ion and a slightly distorted square planar geometry (see
Figure 2.6 and B.1) that reduce to some extent the intercalation of CuL2+ into the DNA.
Furthermore, the even lower ability to intercalate DNA of ZnII Salphen complexes can
be explained by the non-planar square-based pyramidal geometry where a molecule of
water is in the axial position (see Section 2.3) [19, 63].
2.2.7 Gel electrophoresis of ML-DNA solutions (M = Ni, Cu, Zn)
Plasmid Gel Electrophoresis. Gel electrophoresis of negative-supercoiled and open-
circle plasmid DNA can be used to assess unwinding of the DNA helix caused by small
molecules [80]. The ability of the three complexes here synthesized to induce DNA
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Figure 2.19: Differential DNA LD signal at 260 nm as a function of the NiL2+ (squares), CuL2+
(circles) and ZnL2+ (triangles) concentration.
unwinding was studied by gel electrophoresis using negatively supercoiled plasmid
DNA pBR322. The characteristic agarose gel pattern of plasmid DNA consists of two
bands, one corresponding to the negatively supercoiled form and the other to the open
circle form.
It is known that molecules that are able to bind DNA, such as intercalators, induce an
unwinding of the duplex supercoils, giving rise to a decrease of the DNA density, thus
a decrease in the rate of migration through agarose gel [80, 81]. Moreover, if there is
a double strand cleavage, a linear form that migrates between circular and supercoiled
will be generated [82,83]. In Figure 2.20 the 2% agarose gel patterns of the plasmid DNA
pBR322 and the changes caused by the addition of increasing amounts of compounds
NiL2+, CuL2+ and ZnL2+ are shown. While the ZnII and CuII complexes induce just a
weak unwinding of the supercoiled DNA, NiL2+ not only induces a strong unwinding
even at low concentrations (lanes 2,3 Figure 2.20a) but, unexpectedly, produces a cleav-
age of the plasmid in his circular form with formation of linear DNA at higher concen-
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Figure 2.20: Agarose gel electrophoresis patterns for cleavage/unwinding of supercoiled
pBR322 plasmid DNA by NiL2+ (a), CuL2+ (b) and ZnL2+ (c). In each gel the top bands
correspond to the circular plasmid form while the bottom bands to the supercoiled one. In
picture (a) the middle band correspond to the linear form. Lane C: DNA control; Lanes 1-6:
[DNA]/[complex] 20:1; 12:1; 8:1; 6:1; 5:1; 3:1.
trations (lanes 3-6 Figure 2.20a). The geometry of the complexes could play a key role in
determining the activity toward plasmidic DNA. In fact, as described by the linear di-
chroism and by the structural features (Sections 2.2.6 and 2.2.1), the slightly uncoplanar
geometry of CuL2+ and ZnL2+ may affect the binding to DNA. The stronger interacala-
tion of NiL2+ could explain the larger unwinding effect and the nuclease activity of this
compound, as also reported in literature [84].
Polymerase chain reaction (PCR). The polymerase chain reaction, considered a mile-
stone of molecular biology, is a procedure developed for the in vitro amplification of
DNA sequences. It is a technique which has been performed as model of DNA replica-
tion in cells in many studies [85]. Furthermore, PCR is currently used to allow analysis
of DNA extracted from very small amounts of biological samples [85].
In PCR amplification, two oligonucleotide primers are designed to be complement-
ary to the ends of a sequence which has to be amplified and they are mixed in molar
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Figure 2.21: Schematic representation of the first cycle of PCR.
excess with the DNA template and the deoxyribonucleotide triphosphates in a proper
buffer. The solution is first heated to denature the original strands and then cooled to
promote the primer annealing to each different strand of the target fragment. The posi-
tioned primers can be then extended by the action of a DNA polymerase, and the newly
synthesized strands will overlap the binding site of the opposite oligonucleotide. The
steps of denaturation, annealing and extension are repeated cyclically and the primers
bind continuously to both the original DNA template and complementary sites in the
newly synthesized strands and are extended to produce new copies. That leads to an
exponential increase in the total number of DNA fragments, where the majority of the
products synthesized are double strand DNA fragments of a discrete length.
PCR is possible thanks to the presence of a heat resistant DNA polymerase (an en-
zyme) from the thermophilic bacterium Thermus aquaticus (Taq) [85]. In a recent im-
portant work, developed in the M. Hannon research group, where I’ve been as visiting
student, PCR was used for the first time to evaluate the interference of DNA binders
with the biological polymer replication [86]. In this context, polymerase chain reaction
assays were performed to check whether the intercalation of the three metal complexes
could interfere with DNA amplification. In particular, the plasmidic pUC19 DNA was
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Figure 2.22: PCR inhibition assay with ML2+ (M = Ni, Cu, Zn, as shown). 100 bp oligonucleotide
ladders (L); control (1); ML2+ 0.05 µM (2); 0.1 µM (3); 0.3 µM (4); 0.5 µM (5); 1.0 µM (6).
first incubated with increasing concentrations of NiL2+, CuL2+ and ZnL2+ for 5 minutes
at room temperature, then amplified by Taq DNA polymerase. Agarose gel electro-
phoresis patterns of the reaction products after 35 cycles, followed by ethidium brom-
ide staining and UV visualization, showed a single DNA product of the expected length
(Figure 2.22). It can be seen from the intensities of the product bands that just the copper
complex affects drastically the amplification of the DNA. CuL2+ reduces the amplifica-
tion up to 70% with the higher concentration used in the PCR solution. This result was
obtained by measuring the intensities of the bands relative to the control. On the other
hand, both NiL2+ and ZnL2+ do not affect the PCR at the considered concentrations.
In a further experiment the PCR product was incubated with increasing concentrations
of CuL2+ even higher than those used in the first PCR assays to exclude any affection
on the visualization by ethidium bromide (Figure 2.23). The agarose gel (Figure 2.23)
did not show any significant reduction of band intensities. This confirms that CuL2+
interferes with the amplification of the DNA without preventing the ethidium brom-
ide intercalation during the staining step. Although the spectroscopic studies indic-
ate that the intercalation strength is higher for NiL2+ than for CuL2+ and ZnL2+, only
CuL2+ interferes with the DNA amplification. Likely, the combination of the intercala-
tion strength and the distorted geometry of the copper(II) compound have a significant
consequence on the Taq DNA polymerase activity. The zinc(II) complex has a pyramidal
square planar coordination, it is not a good intercalator. Analogously, the nickel(II) com-
pound is an excellent DNA-intercalator, but apparently it does not present the proper
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Figure 2.23: Incubation of CuL2+ complexes with PCR products. Control (1); CuL2+ 0.5 µM (2);
1.0 µM (3); 3.0 µM (4); 5.0 µM (5); 10.0 µM (6).
geometrical features to interfere with the polymerase.
2.2.8 Conclusions
The structural characterization of the NiL2+ and ZnL2+ complexes in aqueous solution
was performed by NMR spectroscopy, while the solid state structure of the CuL2+ com-
plex was established by X-ray crystallography. Concerning the metal complexes-DNA
interaction, spectroscopic studies and, especially, linear dichroism titrations confirmed
that these compounds are certainly DNA-intercalators. The DNA binding affinity de-
creases in the order: NiL2+ > CuL2+ > ZnL2+. In particular, the DNA interaction
strength is slightly weaker for the copper(II) than for the nickel(II) complex probably
due to the slightly distorted square planar structure of the former, as shown by its X-ray
structure. The geometry distortion from coplanarity produces an even weaker DNA-
binding for the zinc(II) compound. Plasmid-DNA gel electrophoresis experiments in-
dicated that while the CuL2+ and ZnL2+ complexes induce a poor unwinding of super-
coiled DNA, the NiL2+ complex has a nuclease activity without the addition of external
agents. On the other hand, the PCR assays demonstrated that only CuL2+ is able to
inhibit the DNA amplification mediated by Taq DNA polymerase. The results obtained
collectively show that the compromise between intercalation strength and geometry
distortion of the copper(II) complex has a key role in interfering with the processivity
of the polymerase.
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2.3 Fluorescence emission and enhanced photochemical
stability of ZnL2+ interacting with native DNA
Schiff base ligands and their metal complexes show interesting photophysical proper-
ties and display comparable fluorescence with excitation maxima at about 300 nm and
emission maxima at about 420 nm [87]. For Salphen and Salen ligands, fluorescence
occurs through the proton transfer between the hydroxy and azomethine groups in the
chromophore. Consequently, the polarity of the solvent has a marked effect [88]. Fluor-
escence emission from intraligand excited states of metal-Salen complexes has also been
detected [89]. In particular, Zn-Salen and related complexes are highly fluorescent and
their spectra are consistent with singlet emission in competition with efficient singlet-
to-triplet intersystem crossing [90,91]. Concerning the photochemical properties of ZnII
complexes of Salen-type Schiff bases, these undergo a ZnII mediated two-electron ox-
idation, due to simultaneous one-electron oxidation of the two imine moieties of the
bridging ligand. In fact, two redox processes at positive potential have been detected:
the first oxidation process is likely localized on the phenolate ring of the Schiff base
ligand while the second oxidation process may be a subsequent oxidation to form dic-
ationic species [92]. Furthermore, when dissolved in relatively acid organic solvents, in
the presence of water, able to coordinate the Zn metal in the apical position, Zn-Salphen
complexes are known to lead to demetallated structures [93].
The photophysical, photochemical and solution properties of ZnII complexes re-
cently reported [87–93] were an incitement to revisit the issue of stability of the ZnL2+
and further investigate the effect of light on its water solutions, also in the presence of
native DNA. Considering the photophysical properties of ZnII-Schiff base complexes
described above, fluorescence spectroscopy measurements were mainly exploited and
supported by quantum chemical calculations.
2.3.1 Photochemistry of ZnL2+ and protective effect of DNA
Preliminary experiments were carried out to ascertain the feasibility of the spectrofluor-
imetric investigation of the photophysical and photochemical properties of ZnL2+ in-
tercalated in native ct-DNA. First of all, the absorption spectra of a buffered aqueous
solution of DNA ([DNA] = 50 µM) and of ZnL2+ ([ZnL2+] = 50 µM) were collected to se-
lect the best suited excitation wavelength. Such spectra are shown in Figure 2.24. Since
42 2. The interaction of DNA with NiII, CuII and ZnII Schiff base complexes
the complex shows an absorption band centered at about 370 nm in a region where
DNA does not absorb, this excitation wavelength was selected for the fluorescence ex-
periments. After detecting a fluorescence band in the 360-700 nm region, suitable ex-
Figure 2.24: Absorption spectra of buffered aqueous solutions of DNA, [DNA] = 50 µM, (- - -)
and of ZnL2+, [ZnL2+] = 50 µM, (—).
perimental conditions and apparatus set up were searched, in order to collect the fluor-
escence spectra without significant sample photodegradation. It was found that, using
the excitation wavelength of 370 nm, an entrance slit width of 0.24 mm and a scan rate
of 6 nm/s nearly identical replicate spectra were collected. Furthermore, in order to
evaluate the photochemical stability of ZnL2+, the fluorescence spectra of some selec-
ted samples at various R values (R = [DNA]:[ZnL2+]) were collected at t = 0 h (freshly
prepared samples) and after 24 h by maintaining the samples at room temperature i)
in the dark or ii) under the illumination of a tungsten lamp (100 watt) placed at a fixed
distance of 30 cm from the quartz cuvette (10 mm path length) containing the sample.
The comparison among these spectra is shown in Figure 2.25. It can be noted that, after
24 h, all the samples maintained in the dark are only marginally affected. On the other
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hand, while the sample without DNA (R = 0) after illumination displays a marked en-
hancement of its fluorescence intensity, by increasing the amount of DNA this effect
progressively disappears being negligible at R = 5. Taking into account that ZnL2+ is in-
tercalated within the DNA structure [21] (see Section 2.2), quite surprisingly this finding
indicates that the insertion of the ZnII complex in the DNA double helix involves an ef-
ficient protection against the observed photochemical process. Moreover, it emphasizes
a novel and interesting functionality of the DNA molecules which could be exploited
for biomedical applications.
In fact, being ZnL2+ representative of potentially interesting DNA intercalating drugs,
this finding could suggest the formulation of photounstable drugs that become pho-
tostable after DNA intercalation. Therefore, it should be of utmost interest to speculate
i) on the nature of this photochemical process and ii) on the ability of the DNA double
helix to hinder it. Measurements performed at different light exposition times show
that the fluorescence intensity of the ZnL2+ solutions exposed to light has a drastic en-
hancement within the first 24 h. After this period, further exposition to light negligibly
changes both the fluorescence intensity and the band shape. Moreover, the fluorescence
spectra of the samples stored in the dark for several days, after prolonged light exposi-
tion, are essentially coincident with those registered immediately after light exposition.
These results allow to conclude that: 1) the photoproduct is stable and 2) the process
is irreversible. Interestingly, the same dramatic intensity enhancement was observed,
after exposure to tungsten light for 24 h, for deoxygenated solutions of the ZnL2+ com-
plex in Tris-HCl 1 mM. The latter were obtained by extensively insufflating nitrogen gas
in the solvent and keeping it under nitrogen atmosphere.
The striking increase in the fluorescence quantum yield of the illuminated ZnL2+ in
the free state strongly suggests the occurrence of a photochemical process resulting in
an increase of the structural rigidity of the zinc(II) complex that remarkably reduces the
radiationless decay rate from the excited to the ground state [94]. An additional support
to this hypothesis comes from the light sensitivity observed in a CoII-Salen-type com-
plex, that is irreversibly photooxidized to a cationic species and in which the electron
is not removed from the metal but from the ligand [95]. Moreover, it has been reported
that a MnIII complex of a Salen-type ligand in CHCl3 is photooxidized to a MnIV com-
plex although, in addition, secondary processes can lead to various photoproducts [96].
Concerning the latter remark, it is known that visible light promotes the oxidation of the
ligand in a MnIII Salen-type complex, followed by the hydrolysis and rearrangement of
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Figure 2.25: Fluorescence spectra of samples at fixed ZnL2+ concentration,[ZnL2+] = 50 µM and
various R ([DNA]:[ZnL2+]) values: a, R = 0; b, R = 0.2; c, R = 0.8; d, R = 2.0; e, R = 5.0; f, R = 10.0,
for t = 0h (- - -), stored in the dark for t = 24h (· · · ) and exposed to tungsten lamp light for t = 24h
(—).
the coordinated Schiff base ligand [97].
According to these considerations and recalling the results by Germain et al. [92],
proving that Salen-type Schiff bases may undergo a ZnII mediated two-electron oxid-
ation, the rationalization of the experimental findings was attempted in terms of the
photooxidation of the ZnL2+ complex, by comparing experimental spectra with those
obtained through TD-DFT calculations.
It should also be noted that the fluorescence spectrum of the aqueous H2L2+ ligand
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Figure 2.26: Fluorescence spectra of aqueous solutions of ZnL2+ and H2L2+, [ZnL2+] =
[H2L2+] = 50 µM, stored in the dark and exposed to tungsten lamp light for 24 h.
is also somewhat influenced by light exposure but, remarkably, it is strongly different
from that of the illuminated ZnL2+ sample at R = 0 (see Figure 2.26). This leads us
to exclude that the observed photochemical process consists in the complex demetall-
ation. An explanation of the latter evidence may be given by considering that bulk
water is known to be a base less strong than water traces dissolved in apolar solvents
(or in relatively acidic solvents such as CHCl3). Moreover, the presence of the Tris-HCl
buffer at neutral pH may enhance the stability of the ZnL2+ complex towards demetall-
ation [93]. To further investigate photochemical stability in water solutions of ZnL2+,
1H-NMR spectra were recorded in D2O for samples stored in the dark and exposed to
tungsten lamp light for 24 h (see Figure 2.27). Remarkably, the 1H-NMR spectrum of
ZnL2+ exposed to light shows the same peaks of the sample stored in the dark. Con-
sidering that the photooxidation of the ZnL2+ complex does not modify significantly its
structure, these findings are consistent with the hypothesis that light exposure causes
partial photooxidation of the ZnL2+ complex.
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Figure 2.27: 1H-NMR spectra of ZnL2+ in D2O, stored in the dark (a) and exposed to tungsten
lamp light for 24 h (b)
2.3.2 Comparison between experimental and calculated absorption and
emission spectra of ZnL2+ and ZnL’
Zn
OO
N N
R R
O
HH
Figure 2.28: Structure of the pentacoordinated aquo-complexes ZnL2+·H2O (H2L2+ = 5-
triethyl ammonium methyl salicylidene ortho-phenylendiimine, R = CH2NEt
+
3 ) and ZnL’·H2O
(H2L’=N,N’-phenylene-bis(salicylideneimine), R = H).
The geometry of the H2L2+ Schiff base ligand and of ZnL2+ ground states, both
the square planar and the pentacoordinated aquo-complexes (see Figure 2.28) [98] as
well as those of their mono and dioxidized forms, was fully optimized by the spin un-
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restricted Density Functional Theory (DFT) B3LYP method [99], using the all-electron
double-zeta split-valence plus polarization (DZVP) basis set [100, 101]. The spin state
of the considered species was singlet (S0) for the lowest oxidation state, doublet (D0)
for the monooxidized form and both singlet (S0) and triplet (T0) spin states for the di-
oxidized forms, respectively. Their absorption spectra were calculated by the Time De-
pendent DFT (TD-DFT) method, by using the same functional and basis set described
above [102–105].
To evaluate the emission spectra of the ZnL2+ aquo-complexes, in the reduced and
dioxidized forms, TD-DFT calculations were performed on the first singlet excited states
(S1) of the ZnII-Salphen simplified model complex, ZnL’ (see Figure 2.28), obtained by
substitution of the two triethyl ammonium methyl cationic groups by two hydrogen
atoms, whose geometry was optimized by the Configuration Interaction Singles (CIS)
method and using the DZVP basis set [106, 107]. Although it is known that the ac-
curacy of the CIS method is comparable to that of the Hartree-Fock method for the
ground state [108], nevertheless the main structural differences between the ground
and first excited states are consistently reproduced by the CIS approach [109]. Implicit
solvent effects in the electronic transitions were considered by single point calculations
within the conductor-like polarized continuum model [110]. All calculations were per-
formed using the Gaussian03 program package. The calculated absorption and emis-
sion electronic spectra were reproduced by the help of the GaussSum-2.1.6 program
package [111].
The absorption spectra of the H2L2+ ligand, of the ZnL2+ tetracoordinated complex
and of the ZnL2+·H2O pentacoordinated complex (Figure 2.28) were calculated by the
TD-DFT method, in the spin states S0 for the lowest oxidation state, D0 for the monoox-
idized form and S0 and T0 for the dioxidized forms. The comparison between calculated
and experimental absorption spectra shown in Figure 2.29, induces the consideration
that in water solution ZnL2+ should be coordinated by an axial water molecule and the
presence of square planar ZnL2+ and/or of the H2L2+ ligand can be safely excluded. In
fact, there is a better matching between the experimental absorption spectrum of ZnL2+,
stored in the dark (Figure 2.29 d) and that calculated for ZnL2+·H2O in the singlet spin
ground state (Figure 2.29 b, see also Figure 2.30 dashed lines).
The latter conclusion is better illustrated by Figure 2.30, where the absorption spec-
trum of ZnL2+·H2O S0 and the average of the two spectra corresponding to the reduced
ZnL2+·H2O S0 and dioxidized ZnL2+·H2O T0 state are reported in Figure 2.30 b. In par-
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Figure 2.29: Calculated absorption spectra (#calcd) and oscillator strengths (f ) of ZnL2+ (a),
ZnL2+·H2O (b) and H2L2+ (c) in the reduced S0 state (—), in its monooxidized D0 state (—)
and in the dioxidized S0 (—) and and T0 (—) spin states, within the implicit water solvent; (d)
experimental absorption spectra of ZnL2+ ([ZnL2+] = 5×10−5 M), stored in the dark (—) and
exposed to the tungsten lamp light for 24 h (—).
ticular, the similarity between the calculated absorption spectrum obtained by a 50%
mixture of the S0 ZnL2+·H2O and T0 ZnL4+ ·H2O with experimental absorption spec-
trum of illuminated ZnL2+ in water solution, supports the hypothesis that the effect of
the tungsten lamp light for 24 h is to partially oxidize ZnL2+ to ZnL4+, up to an approx-
imately equimolar ratio between the two forms. To understand the role of light exposure
on the fluorescence emission of ZnL2+ water solutions, the structure of the first excited
state of simplified model complexes ZnL’·H2O and ZnL’2+·H2O (see Figure 2.28) was
calculated by the CIS method, in the S1 spin states for both the reduced and the diox-
idized states (see Experimental Section 2.5). Their emission spectra calculated by the
TD-DFT method are shown in Figure 2.31. Despite the remarkable difference between
the experimental fluorescence intensities of ZnL2+ solutions stored in the dark and il-
luminated, due to their different nonradiative decay rates, the shape of the calculated
emission spectra in Figure 2.31 reproduces the two key spectral changes accompanying
2.3. Fluorescence emission and enhanced photochemical stability of ZnL2+ 49
Figure 2.30: Experimental absorption spectra of ZnL2+ (a) and calculated spectra of ZnL2+·H2O
within the implicit water solvent (b): (a) experimental ([ZnL2+] = 5×10−5 M), stored in the dark
(- - -) and exposed to the tungsten lamp light for 24 hours (—); (b) reduced S0 state (- - -) and
50% mixture of the reduced S0 state and dioxidized T0 state (—)
the exposure to light. In fact, in the experimental spectrum (Figure 2.31 a) the peak at
420 nm is red shifted in the illuminated ZnL2+ solutions and the intensity of the peak
at 480 nm decreases compared to that at 420 nm. Moreover, the analysis of Figures 2.29
and 2.31 shows that the ground state of the dioxidized ZnL2+ aquo-complex is a triplet
spin state, while the emission from the first excited state of the dioxidized species oc-
curs from the S1 singlet spin state, presumably following a triplet to singlet intersystem
crossing.
Noteworthy, the increase in the positive charge accompanying the two-electron ox-
idation process, may well explain the increase of the photoinduced structural rigidity
of the cationic zinc(II) complex, as deduced above from the analysis of the experimental
spectra (see Figure 2.25 a). The most intense electronic transitions of the absorption
spectra calculated for ZnL2+·H2O S0 and for ZnL4+·H2O T0 (see Figure 2.29 b) and of the
emission spectra calculated for ZnL’·H2O S1 and for ZnL’2+·H2O S1 (see Figure 2.31 b),
can be attributed to electronic transitions among the Molecular Orbitals (MOs) depicted
in Figure 2.32, as detailed in Table 2.4.
Interestingly, it can be noticed that the contribution of the orbitals centered on the
metal ion is negligible in all the MOs represented Figure 2.32. This result shows that the
calculated electronic transitions, of both the absorption and emission spectra, involve
intraligand states, in agreement with the attributions reported in the literature [89].
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Table 2.4: Attribution of the most intense calculated absorption and emission transitions of the
considered ZnII complexes (see Figures 2.29 b and 2.31 b) to the frontier molecular orbitals es-
sentially involved (see Figure 2.32).
Compound λ (nm) Attribution
ZnL2+·H2O-S0
297 HOMO-4 $→ LUMO 61%
371 HOMO $→ LUMO+1 69%
415 HOMO $→ LUMO 89%
ZnL4+·H2O-T0
388 HOMO-6 $→ LUMO+1 35%
393 HOMO-6 $→ LUMO+1 31%
480 HOMO $→ LUMO 39%
ZnL’·H2O-S1 398
HOMO-1 $→ LUMO 44%
HOMO $→ LUMO+1 36%
ZnL’2+·H2O-S1
489 HOMO $→ LUMO 87%
410 HOMO-5 $→ LUMO 89%
490 HOMO $→ LUMO+1 57%
Figure 2.31: (a) Experimental fluorescence spectra of ZnL2+, [ZnL2+] = 5×10−5 M, stored in
the dark (- - -) and exposed to the tungsten lamp light for 24 hours (—)); (b) calculated emis-
sion spectra (#calcd) and oscillator strengths (f ) for the simplified ZnL’·H2O complex, within the
implicit water solvent, reduced S1 state (- - -) and dioxidized S1 state species (—)).
Moreover, it is worth considering that the triethyl ammonium methyl groups are es-
sentially not involved in the MOs of both ZnL2+·H2O and ZnL4+·H2O shown in Fig-
ure 2.32. This suggests that ZnL’·H2O is a reliable model for describing the excited
state of ZnL2+·H2O. Table 2.5 shows the relevant bond lengths and angles involving the
oxygen and nitrogen atoms coordinated to the Zn atom in the four metal complexes
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Figure 2.32: Molecular orbitals involved in the electronic transitions calculated for the absorp-
tion spectra of the ZnL2+·H2O S0 and of the dioxidized ZnL4+·H2O T0 (top rows) and for the
emission spectra of the corresponding simplified models, ZnL’·H2O S1 and ZnL’2+·H2O S1 ex-
cited states (bottom rows).
ZnL2+·H2O, ZnL4+·H2O, ZnL’·H2O and ZnL’2+·H2O. The geometry of the first singlet
excited state of the reduced and oxidized forms of the ZnII complex has been obtained
on a simplified system (see Figure 2.28) and using the CIS method. The latter is less
accurate than the B3LYP method used for the description of the reduced and oxidized
forms in the ground state. Nevertheless the analysis of Table 2.5 suggests that only
minor structural modifications occur on the coordination site of the title complex when
it is photooxidized and/or when it is photoexcited. However, interestingly, such small
distortions largely take into account of the remarkable spectral differences, experiment-
ally detected both in the absorption and in the emission electronic transitions (see Fig-
ures 2.29 and 2.30).
According to this picture, the protective action of DNA toward the intercalated
ZnL2+ can be attributed to the inhibition of the ZnL2+ photooxidation through an ef-
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Table 2.5: Relevant geometrical parameters (A˚ and ◦) of the compounds ZnL2+·H2O S0 and
ZnL4+·H2O T0, optimized by the B3LYP/DZVP method and of the compounds ZnL’·H2O S1
and ZnL’2+·H2O S1, optimized by the CIS/DZVP method (see Fig. 1 for atom labels).
ZnL2+·H2O S0 ZnL4+·H2O T0 ZnL’·H2O S1 ZnL’2+·H2O S1
Zn-O1 1.994 2.043 1.985 1.985
Zn-O2 2.001 2.042 1.988 1.989
Zn-N1 2.117 2.113 2.124 2.153
Zn-N2 2.122 2.112 2.113 2.155
Zn-OH2 2.178 2.103 2.230 2.143
O1-Zn-O2 100.2 94.5 105.2 102.6
N1-Zn-N2 78.0 79.3 78.2 75.7
O1-Zn-N2 89.0 88.2 88.2 87.0
N1-Zn-O2 161.2 156.2 166.0 156.8
fective stabilization of its ground S0 state (see Figure 2.25). The occurrence of ZnL2+
photooxidation in bulk water solution induces to hypothesize that an electron transfer
takes place from each of the salicylideneimine groups to a water molecule. It is worth
in fact recalling that the same photooxidation process also occurs in deoxygenated solu-
tions (see above). Hence, a possible explanation of the way by which DNA hinders this
process and protects ZnL2+ from the photooxidation, can be given considering that the
DNA-intercalated ZnL2+ compound is in a more hydrophobic region, less accessible to
water molecules (see below). Then, in agreement with the above reported findings, to
investigate the photophysical properties of intercalated ZnL2+, all the subsequent fluor-
escence experiments were carried out using samples prepared and stored in the dark
before each measurement.
2.3.3 Steady-state and time-resolved photophysical properties of ZnL2+
intercalated in native DNA
Under excitation at 370 nm, ZnL2+ aqueous solutions show an intense structured emis-
sion band centered at 483 nm, whose intensity increases in the presence of DNA. The
increase of the fluorescence intensity is accompanied by a red-shift of the fluorescence
maximum (see Figure 2.33). These findings are typical clues of the occurrence of an in-
tercalation process and in particular indicates that in the intercalated state the complex
experiences (i) an environment less polar than water or (ii) a restriction of molecular
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motions or (iii) solvent relaxation that deactivates the excited state without emission of
a photon [112]. In particular, by adding increasing amounts of DNA at fixed complex
concentration, the emission intensity at the band maximum is progressively enhanced
reaching a plateau at R = 3 (R = [DNA]:[ZnL2+]) corresponding to a binding size of
about 0.7 per base pairs which is in fair agreement with the literature value [21] (see
Section 2.2).
Figure 2.33: Fluorescence spectra of solutions of the ZnL2+ complex, stored in the dark, in the
presence of increasing amounts of DNA at fixed ZnL2+ concentration ([ZnL2+] = 50 µM). In the
inset the intensity (Imax) at the emission band maximum is reported as a function of R.
By plotting the fluorescence intensity at the band maximum as a function of R (inset
in Figure 2.33), it can be noted that a short induction regime (phase 1) in the region
0<R<0.8 was characterized by a nearly linear increase followed by a rapid increase
(phase 2) and finally a trend toward a plateau (phase 3). This peculiar behaviour reveals
the existence of different binding regimes of ZnL2+ to the DNA double helix. It is worth
to note that during phase (1), although the fraction of intercalated ZnL2+ is small, the
DNA is completely saturated by ZnL2+ while the major part of the complex is in the
aqueous medium or surrounding the DNA molecule. Accordingly, regime (1) could be
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attributed to the depletion of ZnL2+-layers nearest the DNA surface [91]. Then, further
increasing of the DNA concentration in the region 0.8<R<3, together with an increase of
the fraction of DNA-intercalated ZnII complex, the concentration of ZnL2+ outside tends
to vanish. Finally, when the DNA concentration is very high all the ZnL2+ molecules are
totally secluded within the DNA double helix. On the other hand, by considering the
behavior of the wavelength at the maximum of the emission band (see Figure 2.34a), a
bathochromic shift occurs in the 0<R<2 range followed by a hypsochromic shift at R>2.
This finding indicates that this parameter monitors a different aspect of the intercalation
process. Specifically, it is a fine probe of the environment experienced by ZnL2+. The
region where the bathochromic shift occurs corresponds to an increase of the fraction
of the complex intercalated. On the other hand, the region of the hypsochromic shift
reveals that, during the dilution process of ZnL2+ among the DNA binding sites, some
changes of the DNA interior, involving an increase of its polarity, occur.
Figure 2.34: (a) Wavelength at the band maximum as a function of R (horizontal lines indicate
the max value of ZnL2+ in the specified solvent medium). (b) Fluorescence spectra of ZnL2+ at
fixed concentration ([ZnL2+] = 50 µM) in the specified solvent medium.
In order to estimate the environment sensed by the intercalated complex, its spec-
trum was also collected in methanol and ethanol. The comparison with that in aqueous
solution is shown in Figure 2.34b. It can be noted that the wavelength at the band
maximum in water (482 nm, dielectric constant 78) shifts to about 488 nm in methanol
(dielectric constant 32.6) and to 510 nm in ethanol (dielectric constant 24.3). Consider-
ing that the highest wavelength value at the band maximum observed in the presence
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of DNA is 495 nm, it can be concluded that the intercalated complex experiences an en-
vironment whose polarity is between that of methanol and ethanol. Further insights on
the environment sensed by the intercalated complex were searched by monitoring the
time-resolved fluorescence spectra of the complex in aqueous solution of native DNA.
These spectra can be consistently described in terms of two exponential decay functions
where, according to the literature, the faster decay characterized by a quite constant
relaxation time of about 0.2 ns can be attributed to the sample scattering [74–76]. On
the other hand, the second decay, attributable to the excited ZnL2+ complex, is char-
acterized by a relaxation time which changes little going from the bulk aqueous phase
(1.1 ns) to the DNA-intercalated state (0.9 ns). This piece of experimental result can be
taken as an indication that the complex intercalation does not involve significant restric-
tion of its molecular motions which should lead to a decrease of the nonradiative decay
rate [113]. Moreover, the existence of a single decay time for the intercalated complex
points toward the existence of nearly homogeneous binding sites.
2.3.4 Conclusions
The fluorescence intensity of the cationic complex ZnL2+, in water solution at neutral
pH, dramatically increases in the range 360-700 nm by exposure of the solution samples
to tungsten light. Surprisingly, experimental results indicate that, in the intercalated
state, ZnL2+ is effectively protected from this photochemical process. Quantum chem-
ical calculations allowed us to suggest that in the free state ZnL2+ undergoes a pho-
toinduced two-electron oxidation process and, consequently, the protective action of
DNA toward the intercalated ZnL2+ can be attributed to an effective inhibition of the
ZnL2+ photooxidation. The latter conclusion is in agreement with the result that DNA-
intercalated ZnL2+ is confined in a region less polar than water and inaccessible to this
solvent, possibly being water the electron acceptor molecule of the ZnL2+ photooxida-
tion. Information achieved by steady state and time-resolved fluorescence spectroscopy
indicates that the polarity of the environment probed by ZnL2+, intercalated within
DNA, is between that of methanol and ethanol and shows a continuous variation with
the DNA to complex molar ratio. Indirectly, this finding allows to hypothesize that the
structure of the DNA double helix progressively changes by increasing the fraction of
occupied binding sites. From a more general perspective, the capability of DNA mo-
lecules to protect intercalated species from photodegradation processes seems to be of
utmost importance from a biological point of view and could be amenable to biomedical
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applications.
2.4 Confinement effects on the interaction of native DNA
with CuL2+ in C12E4 liquid crystals
Among the various topics concerning the deoxyribonucleic acid macromolecule, its con-
finement in reduced space and its interaction with intercalating molecules are of cur-
rent scientific interest and have been separately widely investigated [114–120]. While
confinement investigations attempt to characterize the peculiar structural and dynamic
properties of DNA, mimicking the conditions experienced in vivo, those on the inter-
calation aim to define the specific interactions and the microscopic mechanisms in-
volved in the binding of chemical species, thus allowing to state the molecular fea-
tures they should possess to effectively stick to the DNA backbone. This knowledge
is thus pivotal to select substances that could be employed as diagnostic, protective or
therapeutic agents or to develop novel specialized molecules able to control genetic in-
formation and/or to avoid growth and replication of cancerous cells by transcription
inhibition [121–125]. However, it is reasonable to foresee that the intercalation process
could be influenced by the chemical environment in which the DNA is located and, in
particular, by the compaction degree of its tertiary structure [126]. But, in spite of the
relevant interest in this specific research field, studies focused on the intercalation of
transition metal complexes characterized by ideal intercalative features (extended aro-
matic moiety and planarity) in the backbone of DNA confined in biomimetic nanoscopic
domains are absent in the literature.
Prompted by this consideration, the interaction of CuL2+ with DNA was studied in
a microheterogeneous system, to segregate DNA in a nanoscopic domain (tetraethyl-
ene glycol monododecyl ether liquid crystals). The experimental techniques selected
for the investigation were UV absorption spectrophotometry, circular dichroism and
small angle X-ray scattering (SAXS). The comparison of the experimental results with
those previously obtained in aqueous solution allows to emphasize the role of the con-
finement effects on the structure of DNA and on its interaction with the CuII cationic
complex [21] (see Section 2.2).
Tetraethylene glycol monododecyl ether (C12E4), an amphiphilic substance with for-
mula CH3(CH2)11(OCH2CH2)4OH, was chosen for the present study because it has been
suggested that non-ionic surfactants show low affinity with polyelectrolytes such as
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DNA, thus allowing confinement effects to be studied without the introduction of spe-
cific electrostatic interactions, which greatly contribute to the observed behaviour [127].
Furthermore, in the investigated temperature and composition range, C12E4 forms a
dense phase of reverse micelles entrapping in their core water molecules [128,129]. The
solubilization of increasing amounts of water or aqueous solutions in C12E4 liquid crys-
tals causes a progressive increase of the micellar radius until a structural transition to
a lamellar phase occurs [130, 131]. Generally, the presence of few small-size molecules
does not significantly alter the reverse micellar structure. However, the entrapment of
macromolecules is expected to alter drastically the size and shape of the hosting aggreg-
ate [132].
Only a few studies on DNA confined in reverse micelles have been published [133,
134]. It has been shown that DNA within reverse micelles is condensed in compact
structures (size 50-400 nm) and this process is accompanied by a hypochromic effect,
a red shift of the absorption maximum and changes in the CD spectra. For anionic
and cationic reverse micelles, electrostatic interactions have been invoked to rational-
ize these experimental findings while, for non-ionic surfactants, it has been suggested
that the spatial restriction imposed by reverse micelles and the relatively low dielectric
constant of its polar core are the main contributions [133, 134].
Finally, this study could shed some light on the peculiarity of drug-DNA interactions
occurring within the intracellular environment. This section is organized as follows:
each paragraph reports and discusses the results of the title technique applied to DNA
in water and in C12E4, then to CuL2+ in water, DNA + water and DNA + C12E4.
2.4.1 UV-visible absorption
Lyophilized ct-DNA displays in aqueous solution an absorption band centred at 258
nm characterized by a molar extinction coefficient at the band maximum ("max) of 7000
M−1 cm−1 [135–138]. On the other hand (see Figure 2.35), when it is solubilized in C12E4
liquid crystals (DNA, W/C12E4 at Rw/s = 3, where Rw/s = [Water]/[C12E4]), the band is
red shifted (λmax = 260 nm) and "max diminishes ("max = 5849 M−1 cm−1).
Taking into account that this band is due to pi → pi∗ and n→ pi∗ electronic transitions
involving the aromatic rings of the DNA base pairs and that the related transition mo-
ments decrease by increasing the interactions among adjacent base pairs, the observed
"max change suggests that the DNA confinement within C12E4 reverse micelles and/or
the reduced hydration of DNA cause a closer approach, along the double helical axis
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Figure 2.35: UV spectra of DNA, W ([DNA] = 146 µM) and DNA, W/C12E4 system at various
Rw/s values (Rw/s = 1 and [DNA] = 46 µM, Rw/s = 2 and [DNA] = 88.1 µM, Rw/s = 3 and [DNA]
= 126 µM). The inset shows the absorbance at the band maximum (Amax) as function of DNA
concentration.
and/or a more favourable orientation of the base pairs. The red shift of the band max-
imum indicates that also the energetic gap of the molecular orbitals involved in the
transition is consequently affected by DNA confinement and/or reduced hydration.
Table 2.6: Wavelength (λmax) and molar extinction coefficient (#max) at the band maximum of
DNA in aqueous solution and in C12E4 reverse micelles at various Rw/s
Rw/s λmax (nm) "max (M−1 cm−1)
1 262 5956
2 261 6470
3 260 5849
Aqueous Solution 258 7000
The effect of the water content of the C12E4 reverse micelles on the DNA band para-
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Figure 2.36: DNA band of the DNA, W/C12E4 at Rw/s = 3 sample at 25
◦C and after the thermal
treatment shown.Inset: absorbance at the band maximum as function of temperature for DNA,
W (squares) and DNA, W/C12E4 (circles, Rw/s = 3). [DNA] = 126 µM.
meters was investigated by recording the UV spectra of samples at various Rw/s values
shown in Figure 2.35 and collecting the λmax and "max values summarized in Table 2.6.
The linear trend of the band intensity (Amax) with the DNA molar concentration, in the
inset of Figure 2.35, shows that the Lambert-Beer law is fulfilled in all the samples im-
plying the absence of a DNA structural transition in the investigated Rw/s range. From
an inspection of Table 2.6, it can be argued that by decreasing Rw/s, i.e. by reducing the
water content of reverse micelles, there is an increasing deviation of λmax with respect to
the value in aqueous solution while "max does not show a definite trend. This suggests
that λmax is more sensitive to change of the DNA hydration whereas "max is sensitive to
base pair interactions.
Further information on the state of DNA confined in C12E4 reverse micelles has been
gained by holding for 30 and 60 minutes the DNA, W/C12E4 sample at Rw/s = 3 at 50,
60 and 70 ◦C in a thermostatic bath and immediately after collecting the UV spectra
at 25 ◦C (see Figure 2.36). Surprisingly, a marked and irreversible decrease of the band
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intensity by increasing the temperature of the thermal treatment and a modest reduction
with its duration was observed. This indicates the occurrence of DNA condensation in
a more compact structure at increasing values of the temperature. This behaviour is
opposite to that occurring in aqueous solutions where an increase of the temperature
above the DNA melting point (Tm ≈ 53 ◦C) causes an absorbance increase, attributed to
a separation of DNA into single filaments (denaturation) [21] (see Section 2.2).
Figure 2.37: UV spectra of CuL2+, W ([CuL2+] = 53.0 µM) and CuL2+, W/C12E4 at Rw/s = 1
([CuL2+] = 10.8 µM), Rw/s = 2 ([CuL
2+] = 20.8 µM) and Rw/s = 3 ([CuL
2+] = 29.7 µM) systems.
The inset shows the absorbance (Amax) at the maximum of the band at ≈ 400 nm as function of
CuL2+ concentration.
The diametric behaviour is also emphasized in the inset of Figure 2.36, where the
absorbance at the band maximum (normalized with respect to the value at 25 ◦C) of the
systems DNA/W and DNA, W/C12E4 at Rw/s = 3 are shown as a function of temperat-
ure. Taking into account that the monolayer of oriented surfactant molecules surround-
ing the DNA macromolecule applies a surface tension on it, it can be hypothesized that
the thermal treatment of the DNA, W/C12E4 at Rw/s = 3 makes accessible DNA trans-
itions toward more compact structures.
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Figure 2.38: UV-vis spectra of: panel (a) DNA, W ([DNA] = 150 µM) and DNA, CuL2+, W
([CuL2+] = 53.0 µM); panel (b) DNA, W/C12E4 and DNA, CuL2+, W/C12E4 at Rw/s = 1 and
[CuL2+ ] = 19.5 µM; panel (c) DNA, W/C12E4 and DNA, CuL2+, W/C12E4 at Rw/s = 2 and
[CuL2+ ] = 37.2 µM; panel (d) DNA, W/C12E4 and DNA, CuL2+, W/C12E4 at Rw/s = 3 and
[CuL2+] = 53.2 µM. In all samples containing CuL2+ R = 1 (R = [DNA]:[CuL2+ ]).
Confinement effects on the intercalation of CuL2+ in the DNA structure were em-
phasized by collecting the UV spectra of CuL2+ and of the CuL-DNA system in water
and in C12E4 reverse micelles at various Rw/s. These spectra are shown in Figures 2.37
and 2.38. Among the various features, the band at about 400 nm entirely attributable to
CuL2+ is of utmost importance because DNA spectral contributions are absent in this
region. The λmax and "max parameters of this band are summarized in Table 2.7.
The linear trend shown in the inset of Figure 2.37 shows that the Lambert-Beer law
is fulfilled in the investigated systems. Moreover, an analysis of the band parameters
of Table 2.7 concerning CuL2+ and the CuL-DNA system in water and in C12E4 reverse
micelles at various Rw/s indicates intercalation through the stacking interaction of the
aromatic rings of CuL2+ and the base pairs of DNA mainly leading to band red shift [21].
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Table 2.7: Wavelength (λmax) and molar extinction coefficient (#max) at the band maximum of
CuL2+ (about 400 nm) and of the system DNA-CuL2+ in water and in C12E4 reverse micelles at
various Rw/s
Rw/s
λmax (nm) "max (M−1 cm−1) λmax (nm) "max (M−1 cm−1)
CuL2+ CuL2+ DNA-CuL2+ DNA-CuL2+
1 413 1.59×104 414 1.26×104
2 412 1.70×104 414 1.31×104
3 411 1.72×104 414 1.27×104
Aqueous Solution 396 1.55×104 401 1.34×104
In C12E4 reverse micelles, the mean change of λmax (∆λmax = 2 nm) due to intercalation
is lower than that in aqueous solution (∆λmax = 5 nm) while that of "max (∆"max ≈ −0.4×
104) is greater (∆"max = −0.21 × 104). These departures from the behaviour observed
in aqueous solution emphasize that the CuL2+ interaction with DNA is influenced by
different microscopic events.
Further information on the state of the CuL-DNA system confined in C12E4 reverse
micelles has been gained by holding for 30 and 60 minutes the DNA, CuL2+, W/C12E4
sample at Rw/s = 3 at 60 and 70 ◦C in a thermostatic bath and immediately after collect-
ing the UV spectra at 25 ◦C (see Figure 2.39). It is of interest that the spectrum of con-
fined DNA + CuL2+ complex is slightly affected by the thermal treatment. This means
that CuL2+ intercalated in the DNA confined within C12E4 reverse micelles partially
neutralizes the negative charges of the phosphate groups, stabilizing its double-helical
structure and thus inhibiting the changes induced by the thermal treatment. Together
with the intrinsic importance of this finding, it confirms the CuL2+ intercalation in the
DNA double helix.
2.4.2 Circular Dichroism
The CD spectrum of lyophilized ct-DNA in buffered aqueous solution displays a posit-
ive band centred at 270 nm due to the stacking of base pairs and a negative band at 240
nm due to the characteristic helicity of right-handed DNA in the B form.
In the case of Z-DNA, DNA with left-handed helicity, a positive band is observed at
260-280 nm and a negative band at 300-350 nm. Moreover, in confined systems at low
water content where DNA takes a compact form (calledΨ-DNA), a strong enhancement
of the band intensity in the region at about 280 nm is observed [133].
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Figure 2.39: UV-vis spectra of the DNA, CuL2+, W/C12E4 at Rw/s = 3 sample at 25
◦C and after
the thermal treatment shown ([CuL2+] = 53.2 µM and R = 1, (R = [DNA]:[CuL2+]).
The CD spectra of native DNA in aqueous solution and in W/C12E4 at various Rw/s
are shown in Figure 2.40. It can be noted that there are marked differences in the spectral
shape with respect to that registered in aqueous solution: a very intense positive band
at 267 nm and the appearance of a negative band at about 300 nm both linearly related
to the DNA concentration (see inset of Figure 2.40). This finding suggests that DNA
confined in C12E4 reverse micelles undergoes a compaction presumably accompanied
by a transition from a right- to left-handed helix.
A further contribution could arise from the chiral binding of the surfactant to the
DNA double strands. It can be hypothesized that DNA condensation is driven by the
low local dielectric constant of the reverse micellar cores that increasing the electrostatic
interactions causes a partial neutralization of the charges residing on the DNA back-
bone. Additional contributions might arise from the tension on its surface due to the
monolayer of adsorbed surfactant molecules. Moreover, looking to the CD spectra at
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Figure 2.40: CD spectra of DNA, W/C12E4 at Rw/s = 1 ([DNA] = 46.0 µM), Rw/s = 2 ([DNA] =
88.1 µM) and Rw/s = 3 ([DNA] = 125.0 µM) and DNA, W ([DNA] = 100 µM) systems. The inset
shows molar ellipticity values at the positive band maximum (circles) and at the negative band
minimum (squares) as a function of the DNA concentration.
various Rw/s, it seems reasonable to conclude that in the investigated Rw/s range the
compaction of DNA is favoured by an increase of its hydration degree. On the other
hand, the transition from B to Z-DNA can be considered to be a consequence of its con-
finement in the reverse micellar core.
Further information on the state of ct-DNA confined in C12E4 reverse micelles has
been gained by holding for 30 minutes the DNA, W/C12E4 sample at Rw/s = 3 at 50, 60
and 70 ◦C in a thermostatic bath and immediately after collecting the CD spectra at 25
◦C (see Figure 2.41). It can be noted that the intensity of the positive band at 280 nm,
after an initial decrease, at T > 60 ◦C increases dramatically while the negative band
at 300 nm disappears. This behaviour emphasizes that the thermal treatment causes
different effects: increases the DNA compaction and at the same time inhibits the B- to
Z-DNA transition.
Confinement effects on the CuL2+ interaction with the DNA macromolecule were
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Figure 2.41: CD spectra of DNA, W/C12E4 at Rw/s = 3 sample at 25
◦C and after the thermal
treatment shown.
also emphasized by recording the CD spectra of CuL2+ and of the CuL-DNA system
in water and in C12E4 reverse micelles at various Rw/s. These spectra, with the solvent
contribution subtracted, are shown in Figure 2.42. Comparing these spectra with those
shown in Figure 2.40, it can be noted that there are marked changes in the shape of the
CD spectra induced by the presence of CuL2+. These findings suggest unequivocally
the occurrence of a DNA-interaction by CuL2+ and, at the same time, of significant
perturbations of the DNA helicoidal structure. Moreover, notwithstanding that CuL2+
is not chiral, its binding to the DNA determines an induced CD band occurring at λ
> 380 nm, i.e. in a spectral region where the DNA does not show CD contributions.
This finding suggests that CuL2+ is tightly bonded and adopts the dominating chiral
organization of the DNA double helix [139].
Other effects due to CuL2+ intercalation are shown in Figure 2.43 where the CD
spectra of the DNA, CuL2+, W/C12E4 sample at Rw/s = 3 at 25 ◦C and after the thermal
treatment at 60 and 70 ◦C for 30 minutes are reported. It can be noted that at T = 60 ◦C,
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Figure 2.42: CD spectra of DNA, CuL2+, W/C12E4 at Rw/s = 1 ([DNA] = 42.0 µM), Rw/s = 2
([DNA] = 81.1 µM) and Rw/s = 3 ([DNA] = 114.0 µM) and DNA, CuL
2+, W ([DNA] = 100.0 µM);
R = 2 (R = [DNA]:[CuL2+])
the CD spectrum is slightly affected with respect to that at 25 ◦C while at T = 70 ◦C a
dramatic change with the formation of a highly compact and ordered DNA superstruc-
ture.
2.4.3 Small Angle X-Ray Scattering
Figure 2.44 shows the scattering profiles of W/C12E4 and DNA, W/C12E4 samples at the
investigated Rw/s and of the DNA, CuL2+, W/C12E4 sample at Rw/s = 3. It can be noted
that all the spectra are characterized by an intense absorption at the lower q due to the
beam stop and an interference peak with a maximum at about q∗ ≈ 0.17 A˚−1 whose
position decreases with Rw/s. Taking into account that in the investigated composition
range C12E4 forms a dense L2 phase of reverse micelles, the Bragg distance (d = 2pi/q)
can be identified with the micellar core diameter [128, 129]. The q and d values are
collected in Table 2.8.
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Figure 2.43: CD spectra of DNA, CuL2+, W/C12E4 (Rw/s = 3; [DNA] = 114.0 µM; [CuL
2+] = 53.2
µM) sample at 25 ◦C and after the thermal treatment shown.
Figure 2.44: SAXS patterns of W/C12E4 and DNA, W/C12E4 samples at various Rw/s and of the
DNA, CuL2+, W/C12E4 sample at Rw/s = 3.
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A linear increase of the reverse micelle diameter (d) and a decrease of the peak width
(w) with Rw/s have been found. These findings are consistent with a progressive in-
crease of the aqueous micellar core size accompanied by a parallel increase of the local
structural order in the C12E4 liquid crystals [140].
Table 2.8: Structural parameters of the investigated samples
System q (A˚−1) d (A˚) w (A˚−1)
W/C12E4, Rw/s = 1 0.182 34.5 0.068
DNA, W/C12E4, Rw/s = 1 0.184 34.1 0.069
W/C12E4, Rw/s = 2 0.163 38.5 0.048
DNA, W/C12E4, Rw/s = 2 0.164 38.3 0.051
W/C12E4, Rw/s = 3 0.148 42.4 0.037
DNA, W/C12E4, Rw/s = 3 0.149 42.2 0.039
CuL2+,DNA, W/C12E4, Rw/s = 3 0.148 42.4 0.037
The extrapolated d value at Rw/s = 0 is 31.3 A˚, which is in agreement with the liter-
ature value (32.5 A˚) [131]. It is worth noting that the d values are always much smaller
than the ct-DNA size [141–143]. This indicates that the micellar aggregates containing
this macromolecule are bigger than empty micelles.
Comparing the structural parameters of samples at the same Rw/s, it can be also
noted that the d value of the DNA, W/C12E4 samples is slightly lower than that of the
W/C12E4 samples whereas the peak width is slightly larger. These findings suggest that
the hydration of the DNA macromolecule diminishes the amount of water disposable
for empty reverse micelles while its presence involves an increase of the local disorder.
Finally, the d and w values concerning the DNA, CuL2+, W/C12E4 sample at Rw/s = 3
indicate that the intercalation of CuL2+ in the DNA backbone determines a decrease of
its hydration degree.
2.4.4 Conclusions
This investigation shows that ct-DNA can be stably solubilized in the non-ionic surfact-
ant C12E4 in the presence of small amounts of water and that this process determines
dramatic changes of its structural properties. The experimental results obtained by UV-
vis spectrophotometry, circular dichroism and small angle X-ray scattering consistently
indicate that DNA is confined in the hydrophilic core of C12E4 reverse micelles, strongly
perturbed by its presence. The confinement causes the formation of more compact and
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thermoresistent DNA structure accompanied by a transition from right- to left- handed.
It has been hypothesized that the DNA condensation in C12E4 reverse micelles is caused
by the low local dielectric constant of the reverse micelle core which increasing the elec-
trostatic interaction determines a partial neutralization of the DNA charges. Further
contributions can arise from the tension on the DNA surface due to the monolayer of
oriented surfactant molecules. It has been found that, as in aqueous solution, CuL2+
intercalates the DNA confined in C12E4 reverse micelles enhancing the stability of its
structure. Within the C12E4 reverse micelles, both the DNA and the CuL-DNA system
display a response to the thermal treatment different from that observed in aqueous
solution. In particular, in aqueous solution and above a critical value, the thermal treat-
ment determines the DNA denaturation whereas, surprisingly, in C12E4 reverse micelles
a strong stabilization of the DNA double helix occurs. This behavior deserves further
investigation for its theoretical and applicative relevance.
2.5 Experimental
2.5.1 Materials and Method
All chemicals and solvents were purchased from Sigma–Aldrich, Fisher or Alfa Aesar
and used as received. Deuterated solvents for NMR were supplied by Cambridge Iso-
tope Laboratories, Inc. and Goss scientific. Ultrapure water (18.2 MΩ, Fisher) was
used in all UV-vis, circular and linear dichroism experiments and for electrophoresis
gel. Lyophilized ct-DNA, purchased from Sigma-Aldrich, was resuspended in tris-
hydroxymethyl-aminomethane (Tris-HCl) pH 7.5 and dialyzed as described in the lit-
erature [144]. The DNA concentration was determined by UV-vis measurements using
the molar extinction coefficient of "258 = 7000 mol−1 dm3 cm−1 per DNA base [135–138].
Proton and carbon nuclear magnetic resonance spectra were recorded on Bruker
AC300 or DRX500 spectrometers.
ESI mass spectra were recorded on a Micromass LCT Time of flight mass spectro-
meter.
Spectroscopic studies
Stock solutions of 1 M NaCl, 1 M Tris-HCl and 100 mM sodium cacodylate buffer
(Na(CH2)2AsO2·3H2O, pH 6.8) were prepared and, together with ct-DNA stock, were
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used to obtain the final work solutions.
Absorption measurements were performed on a Varian Cary 5000 UV-vis double
beam spectrophotometer or on a Varian UV–vis Cary 1E double beam spectrophoto-
meter, both equipped with a Peltier temperature controller, using 1 cm pathlength cu-
vettes.
Circular dichroism spectra were recorded at 25 ◦C on a Jasco J-715 or Jasco J-810 spec-
tropolarimeters, using 1 cm path–length quartz cells. sensitivity, 100 mdeg; wavelength
range, 200 -750 nm; data pitch, 0.5 nm; scanning mode, continuous; scanning speed,
200 nm min−1; response, 0.1 s; bandwidth, 1.0; accumulation, 6. Linear dichroism spec-
tra were collected using a Jasco J-810 spectropolarimeter adapted for LD measurements
with a flow Couette cell, ideal to give an orientation to long molecules such DNA [145].
The following parameters were used: sensitivity, 100 mdeg; wavelength range, 200-750
nm; data pitch, 0.5 nm; scanning mode, continuous; scanning speed, 500 nm min−1;
response, 0.25 s; bandwidth, 2.0; accumulation, 8.
Steady-state fluorescence measurements were made at 25 ◦C using a Horiba Jobin
Yvon spectrofluorimeter (Fluoromax 4) arranged in T-shaped geometry. Time correlated
single photon counting (TCSPC) measurements were carried out using the Fluoromax
4 apparatus equipped with a Single Photon Counting Controller (FluoroHub, Horiba
Jobin Yvon) and a pulsed diode light source (Nanoled, repetition rate 1 MHz, pulse
duration 1.27 ns, 368 nm); data fitting was accomplished using least-squares methods
with DAS6 Fluorescence Decay Analysis Software. All spectra were made using a 10
mm path length cuvette and were corrected for buffer fluorescence.
Small angle X-ray scattering spectra have been collected at 25 ◦C by a Nanostar
(Bruker) equipped with a copper anode Cu Kα, filtered with Ni (λ= 1.5418 A˚) and a
bidimensional detector. Experimental data, the scattering intensity I and the scattering
vector q, related to the scattering angle θ by the equation
q =
4pi
λ
sin
θ
2
(2.4)
have been corrected by subtraction of the cell and solvent contributions.
X-ray crystallography
Crystal data for CuL2+: C34H46CuN4O2, 2(ClO4), 0.5(C6H6), 0.25(CH3NO2), 1.75(H2O),
M = 891.03, triclinic, space group P -1, T = 120 (2) K, a = 9.473 (12) A˚, b = 17.12 (2) A˚,
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c = 28.27 (3) A˚, α = 81.854 (14)◦, β = 89.586 (14)◦, γ = 79.222 (11)◦, V = 4458 (9) A˚3, Z
= 4, 25883 reflections measured, 10983 unique (Rint = 0.2081) which were used in all
calculations. Final R1 (I>2σ(I)) = 0.1225, wR2 (all data) = 0.4126, goodness of fit = 0.947
on F 2.
The dataset was measured on a Crystal Logics diffractometer using a Rigaku Saturn
724+ detector at the Diamond synchrotron X-ray source, beamline I19 (λ = 0.6889 A˚).
The data collection was driven by CrystalClear [146] and unit cell refinement and data
reduction was carried out in Apex2 [147]. An absorption correction was applied using
SADABS [147]. The structure was solved in SIR97 and was refined by a full-matrix least-
squares procedure on F2 in SHELXL-97 [148,149]. All non-hydrogen atoms were refined
with anisotropic displacement parameters. Figures were produced using ORTEP3 for
Windows and Mercury 2.2 [150, 151].
The crystal was the best quality that could be grown but was weakly diffracting,
especially at higher 2θ angles and, despite use of the Diamond synchrotron X-ray source
no diffraction was observed above 2θ 43◦. The dataset was of rather poor quality and
the structure contains highly disordered solvent molecules and these facts are reflected
in the somewhat high agreement statistics.
Gel Electrophoresis
The electrophoresis experiments were performed through Electrophoresis Power Sup-
ply (EPS 301) system with the following parameters: voltage, 120 V; electric current, 190
mA; time, 2.5 h. Gel trays of 210 150 mm with a 15-toothed comb were used. In all of
the electrophoresis experiments 1X Tris acetate (obtained by dilution of 10X TAE, sup-
plied by SIGMA) was used as working buffer. In detail, the gel was prepared warming
up 2 g of agarose (from USB corporation) in 200 mL of 1X TAE. pBR322 plasmide DNA
(1mg/mL, New England Biolabs) was used to prepare the samples. Once incubated
for 1.5 h at 37 ◦C, to each sample 4 µL of loading buffer (30% glycerol and 0.25% bro-
mophenol blue in ultra pure water) were added and 16 µL of each final solution were
loaded in the gel. After electrophoresis the gel was stained in 100 mL of 1X TEA buffer
containing 400 µL of ethidium bromide solution (0.5 µg mL−1) for 15-20 min followed
by a washing with water for 5 min. The images of the gels were visualized and acquired
using a UVtec-uvipro platinum system.
As concerns the PCR gel electrophoresis experiment, twelve reaction mixtures were
prepared, all containing 1X NH4 reaction buffer, MgCl2 (1.5 mM), pUC19 plasmid DNA
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substrate (50 ng, Sigma Aldrich), Taq DNA polymerase (5U; Bioline), dNTPs (3 mM),
the primers (0.4 µM each) pUC19F (5’-CGGTGAAAACCTCTGACACA -3’) and M13
reverse (5’-CAGGAAACAGCTATGACC -3’; Alta Bioscience). The images of the gels
were visualized and acquired using a UVtec-uvipro platinum system.
2.5.2 Synthesis and characterization
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Figure 2.45: Reaction scheme of the ML2+ complex (M = Cu, Ni, Zn, H2L2+ = N,N’-Bis-5-
(triethyl ammonium methyl salicylidene)-1,2-phenylenediamine)
The NiII complex was synthesized as described previously [21, 22, 152]. In brief, 5-
(triethylammoniummethyl) salicylaldehyde chloride (1) and 1,2 phenylendiamine (2)
were mixed in ultrapure water in a 2:1 molar ratio. To this solution one equivalent
of nickel(II) acetate was added and the resulting mixture was stirred for 1h at room
temperature. Finally the compound was isolated as perchlorate salt adding sodium
perchlorate. The orange precipitate was washed with methanol and diethyl ether to
afford the compound as an orange solid. The 5–(triethylammoniummethyl) salicylal-
dehyde chloride ligand was prepared mixing 5–chloromethyl salicylaldehyde [153] and
triethylamine in THF at room temperature for 5h [21].
N,N’-Bis-5-(triethylammoniummethylsalicylidene)-1,2-phenylenediamine-NiII (3a).
The complex was characterized by elemental analysis, NMR, ESI mass analysis and UV-
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vis spectroscopy.
1H NMR (500 MHz, DMSO, 298 K) δ 9.93 (s, 1H, im), 8.18 (dd, J = 6.0, 3.4 Hz, 1H, ar5),
7.77 (s, 1H, ar3), 7.46 (dd, J = 12.2, 6.0 Hz, 2H, ar2 and ar4), 6.99 (d, J = 8.8 Hz, 1H, ar1),
4.39 (s, 2H, a), 3.17 (q, J = 6.8 Hz, 6H, b), 1.34 (t, J = 7.0 Hz, 9H, c).
13C NMR (125 MHz, DMSO) δ 166.5 (q2), 157.8 (im), 142.0 (q4), 139.5 (ar3), 139.0 (ar2),
128.7 (ar4), 123.5 (ar1), 121.1 (q3), 117.4 (ar5), 114.6 (q1), 59.3 (a), 51.9 (b), 7.9 (c). For
numbering scheme see Figure 2.5. 13C DEPT, COSY, HSQC, HMBC NMR spectra are
presented in Appendix A.
Elemental analysis calcd (%) for NiC34H46N4O10C12 (NiL(ClO4)2) : C, 51.0; H, 5.8; N, 7.0;
Cl, 8.9; found: C, 50.5; H, 5.7; N, 7.0; Cl, 9.0. MS-ESI (m/z): 300.2 [NiL]2+.
UV-vis (Tris-HCl): " = 4.76× 104 (λ = 261 nm); " = 1.87× 104 (λ = 352 nm); " = 2.01× 104
(λ = 366 nm) cm−1M−1.
N,N’-Bis-5-(triethylammoniummethylsalicylidene)-1,2-phenylenediamine-CuII (3b).
The general procedure for the synthesis is identical to the one of the compound NiL2+
and was previously reported [21, 152]. Green single crystals suitable for X–ray diffrac-
tion analysis were obtained by slow diffusion of diethyl ether into a solution of CuL2+
(4 mg) in acetonitrile (2 mL), or in CH3NO2/benzene (2 mL). The products were char-
acterized by elemental analysis, ESI mass analysis and UV-Vis spectroscopy.
Elemental analysis calcd (%) for CuC34H46N4O10Cl2 (CuL(ClO4)2): C, 50.72; H, 5.76; N,
6.96; Cl, 8.81; found: C, 49.22; H, 5.69; N, 6.86; Cl, 8.59. ESI mass analysis: m/z = 303.3
[CuL]2+.
UV-vis (Tris-HCl): " = 5.35× 104 (λ = 252 nm); " = 2.49× 104 (λ = 304 nm); " = 1.95× 104
(λ = 334 nm); " = 1.79 × 104 (λ = 397 nm) cm−1M−1.
N,N’-Bis-5-(triethylammoniummethylsalicylidene)-1,2-phenylenediamine-ZnII (3c).
The general procedure for the synthesis is identical to the one of the compound NiL2+
and was previously reported [21, 22, 61, 152]
1H NMR (500 MHz, DMSO, 298 K) δ 9.08 (s, 1H, im), 7.94 (dd, J = 6.1, 3.5, 1H, ar5), 7.56
(d, J = 2.3, 1H, ar3), 7.47 (dd, J = 6.1, 3.4, 1H, ar4), 7.38 - 7.28 (m, 1H, ar2), 6.80 (d, J = 8.8,
1H, ar1), 4.36 (s, 2H, a), 3.16 (q, J = 6.9, 6H, b), 1.33 (t, J = 7.0, 9H, c).
13C NMR (125 MHz, DMSO) δ 173.3 (q2), 163.5 (im), 141.4 (ar3), 139.7 (q4), 138.0 (ar2),
128.2 (ar4), 124.2 (ar1), 119.8 (q3), 117.3 (ar5), 111.7 (q1), 60.0 (a), 51.7 (b), 8.0 (c). For
numbering scheme see Figure 2.5. 13CC DEPT, COSY, HSQC, HMBC NMR spectra are
presented in Appendix A.
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ESI mass analysis: m/z = 303.1 [ZnL]2+.
Chapter 3
The interaction of DNA with NiII, CuII and ZnII
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Doesn’t have a point of view, knows
not where he’s going to, isn’t he a bit
like you and me?
Lennon/McCartney, 1965
3.1 Introduction
Many low molecular weight DNA-binding drugs possess interesting biological prop-erties and have found therapeutical applications in chemotherapeutic anticancer
therapy [154–156]. In particular, the observed cytotoxic properties can be due to either
direct interaction with DNA, with topoisomerases or with DNA-topoisomerase com-
plexes [157]. Metal complexes constitute an important subset of DNA binding com-
pounds, often DNA intercalators and groove binders, characterized by non-covalent
sequence-specific interactions [4, 26, 158, 159].
As far as transition metal complexes are concerned, besides the classic 2,2’-bipyridyl
based ligands, five-membered ring heterocyclic chelators have been recently developed.
This strategy takes advantage of the coordinating ability of pyridine-like nitrogens of
azoles, opening the way to new geometrical structures considering the peculiar coordin-
ation angles of five-membered ring ligands [160].
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Figure 3.1: Structures of a series of PtII complexes of substituted 1,2,4-oxadiazole derivatives
that have shown antitumor activity towards different human tumoral cell lines [31].
It is worth recalling that several five-membered heterocyclic compounds, such as
1,2,4- and 1,3,4-oxadiazoles, have shown a significant in vitro antitumor activity [30].
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In particular, 1,2,4-oxadiazoles [161] have been employed as bioisosteres of bioactive
compounds, as peptidomimetics and enzyme inhibitors, agonists or antagonist of dif-
ferent receptors, genotoxic compounds, apoptosis inducers, or as unnatural bases in the
extension of DNA strands [162–168].
These heterocyclic systems are easily accessible and the modulation of their prop-
erties is achievable through the introduction of appropriate substituents on the cent-
ral heterocycle. In particular, 1,2,4-oxadiazole ligands can be designed so as to chelate
metal ions by the heteroatoms of the ring and of the side chain substituents in the ring
positions 3 and 5.
Oxadiazole-based ligands have been used for complexation of metals such as plat-
inum, silver, palladium and copper [160, 169, 170]. Recently, a series of PtII complexes
of substituted 1,2,4-oxadiazole derivatives (Figure 3.1) have shown antitumor activity
towards human ovarian cancer cell lines, as well as in colon and testicular cancer cell
lines and the results have been correlated to their DNA-binding properties [31].
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Figure 3.2: Structure of the bipyOXA and pyOXA ligands and of their metal complexes (M =
CuII, ZnII, NiII)
Based in the considerations above, the synthesis and characterization of novel 1,2,4-
oxadiazole complexes of NiII, CuII and ZnII were performed, with the aim to obtain
metal compounds with potential antitumor properties. In fact, the three metal ions are
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present as essential elements in the biological intracellular environment of living organ-
isms [171–174]. Moreover, their complexes with planar heterocyclic ligands are efficient
DNA-binders and have a stronger affinity toward DNA than the corresponding isol-
ated ligands [3, 49, 175]. In particular, two 1,2,4-oxadiazole ligands have been selected,
opportunely substituted in both positions 3 and 5 of the ring, 3,5-bis(2’-pyridil)-1,2,4-
oxadiazole (bipyOXA) and 3-(2’-pyridyl)5-(phenyl)-1,2,4-oxadiazole (pyOXA) (see Fig-
ure 3.2). Based on the results of the DNA binding studies, the most promising com-
pound, [Cu(bipyOXA)2(H2O)2](ClO4)2, was also tested against human hepatoblastoma
and colorectal carcinoma cells lines [176].
3.2 Synthesis and structural characterization
The ligand bipyOXA was synthesized through a solvent-free reaction between ami-
doxime 5 and 2- cyanopyridine (4) (see Figure 3.3 and Section 3.6). The same ami-
doxime, together with benzoyl chloride (9) was used to synthesize the ligand pyOXA.
The reaction was conducted in toluene at 130 ◦C (see Figure 3.4).
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Figure 3.3: Synthesis of bipyOXA and of its NiII, CuII and ZnII complexes.
The synthesized CuII, ZnII and NiII complexes of the ligands bipyOXA (Figure 3.3)
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and pyOXA (Figure 3.4) were characterized by elemental analysis, ESI mass spectro-
metry experiments and NMR, including COSY (see Experimental, Section 3.6, and Ap-
pendix A).
Due to their paramagnetism, it was not possible to acquire noiseless NMR spectra
for the copper(II) and the nickel(II) complexes, both presenting an octahedral coordin-
ation geometry (see Figure 3.2) leading to open shell electron configurations. Suitable
crystals for X-ray diffraction analysis were obtained only for the two copper complexes
and their crystal structure is reported in the next paragraph. Nevertheless, elemental
analysis data (see Section 3.6) confirm that the three metal complexes of bipyOXA con-
tain two hydration water molecules, presumably coordinated as in the structure of the
copper(II)-bipyOXA complex.
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Figure 3.4: Synthesis of pyOXA and of its NiII, CuII and ZnII complexes.
3.2.1 X-ray crystallography
The copper complex [Cu(bipyOXA)2(H2O)2]2+ was prepared in ethanol, crystallized
from acetonitrile, and characterized by X-ray crystallography. Its structure consists of
a discrete [Cu(3,5- bis(2’-pyridyl)-1,2,4-oxadiazole)2(H2O)2]2+ cation and two ClO
−
4 an-
ions (Figure 3.5a). The four crystallographically independent molecules constituting the
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a b
Figure 3.5: Crystal structures of the complexes (a) [Cu(bipyOXA)2(H2O)2]2+ and (b)
Cu(pyOXA)2(ClO4)2. The labelling colour scheme is as follows: hydrogen (small open circles),
carbon (dark grey), nitrogen (blue), chlorine (green), copper (orange) and oxygen (red).
asymmetric unit of [Cu(3,5- bis(2’-pyridyl)-1,2,4-oxadiazole)2(H2O)2]2+ are illustrated
in Figure B.3 (see Appendix B). Only few CuII complexes of 1,3,4-oxadiazole ligands
have been synthesized up to now [177–179]. Their X-ray crystallographic structures
show that the coordinated oxadiazoles are co-planar. Interestingly, the CuII ion of the
complex [Cu(bipyOXA)2(H2O)2]2+ lies in a distorted octahedral environment, where
each bipyOXA acts as bidentate ligand and the two ligands are not coplanar. Two co-
ordinated water molecules occupy the cis positions in the equatorial plane. BipyOXA
only uses two of its five potential donor atoms, acting as a typical bidentate chelator. It
forms a five-membered Cu-N-C-C-N metallacycle with a N-Cu-N angle that averages
77.9(2)◦ in the four molecules. The equatorial Cu-N(pyridine) bond distances vary from
2.004(7) to 2.059(6) A˚, and averaging 2.029(6) A˚, while the axial Cu-N(oxadiazole) bond
lengths range from 2.321(6) to 2.388(6) A˚. The Cu-O(water) distances mean 1.987(6) A˚,
while the O-Cu-O angles average 91.7(3)◦. The two non-coordinating ClO−4 counter
anions are involved in hydrogen bonds with the coordinated water molecules, with a
O(water)-O(perchlorate) separation that averages 2.74(1) A˚. The water molecules are
also involved in intramolecular hydrogen bonding interactions with the uncoordinated
nitrogen of one pyridine moiety thus forming a six-membered Cu-N-C-C-N-O metalla-
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cycle. The two pyridine rings of bipyOXA are not coplanar with the oxadiazole ring
and their orientation is forced by the coordination to CuII.
The ligand pyOXA was synthesized from benzoyl chloride and amidoxime 5 (see
Figure 3.4 and Section 3.6). [Cu(pyOXA)2(ClO4)2] crystals, suitable for single crystal X-
ray analysis, were obtained from acetonitrile. Differently from the complex with the lig-
and bipyOXA, [Cu(pyOXA)2(ClO4)2] has no coordinated water molecules (Figure 3.5b).
PyOXA acts as bidentate ligand, and the two ligands are in the same plane and in trans
disposition, with two perchlorate molecules occupying the two apical positions of the
octahedral structure. This results in a neutral complex with a consistently lower water
solubility compared to [Cu(bipyOXA)2](ClO4)2. The ligand forms a five-membered Cu-
N-C-C-N metallacycle with a N-Cu-N angle equal to 80.0(8)◦. The Cu-N(pyridine) bond
distances are equal to 2.00(8) A˚, while Cu-N(oxadiazole) and Cu-O(perchlorate) bond
lengths are 2.02(3) and 2.35(4) A˚, respectively.
3.2.2 NMR spectroscopy
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Figure 3.6: Partial 1H-NMR (CD3CN, 300 MHz) of bipyOXA (upper) and its ZnII complex.
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Figure 3.6 shows the comparison between the 1H-NMR spectra of the ligand bipyOXA
and of its ZnII complex. The complexation of the ligand with the metal center can be
argued by the upfield shift of the protons H1 and H1’ and the downfield shift of the
remaining protons.
Analogously, the comparison between the 1H-NMR spectra of the ligand pyOXA
and its ZnII complex is shown in Figure 3.7. It can be noticed that all the pyridine
protons (H1-H4, Figure 3.7) are shifted to the left part of the spectrum (downfield shift)
while the phenyl protons are slightly shifted to the right part of the spectrum (upfield
shift) or remain essentially in the same position.
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Figure 3.7: Partial 1H-NMR (CD3CN, 300 MHz) of pyOXA (upper) and its ZnII complex.
Taking into account that, according to the crystal structure of its CuII complex (see
Figure 3.5b), the coordinated pyOXA ligands are coplanar, the change in the chemical
shift of the pyridine protons to lower fields can be attributed only to zinc coordina-
tion. In fact, a low field shift indicates that the electron density around the pyridine
protons decreases. The observed chemical shift values of [Zn(bipyOXA)2(H2O)2]2+,
compared to those of the isolated ligand, are more difficult to rationalize, because the
two coordinated bipyOXA ligands are not coplanar, in analogy with the structure of
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[Cu(bipyOXA)2(H2O)2]2+ (see Figure 3.5a). In this case, non bonding (or through space)
interactions could indeed contribute to determine the observed shifts.
3.2.3 ESI Mass spectrometry
The ESI(+) mass spectrum of a methanolic solution of [M(bipyOXA)2](ClO4)2 shows
the presence of different ions attributed to {[M(bipyOXA)2](ClO4 )}+ ,{[M(bipyOXA)2]-
Cl}+, [M(bipyOXA)2 ]+ and {[M(bipyOXA)](ClO4 )}+, respectively and confirmed by
the analysis of their isotopic clusters. Analogous results were obtained for methan-
olic solutions of [M(pyOXA)2](ClO4)2. The data obtained suggest that, in the ioniz-
ation/evaporation process, (i) the species formed in the gas phase are mainly singly
positively charged ions while multiply charged species are not detectable; (ii) the two
coordinated water molecules of the copper(II)-bipyOXA complex are easily lost; (iii)
one perchlorate anion can be replaced by a chlorine; (iv) the copper ion undergoes a
reduction process with the formation of CuI .
3.3 DNA interaction studies
Preliminary spectroscopic measurements indicated that the interaction between DNA
and the isolated bipyOXA ligand is very weak. Furthermore, the shoulder at 340 nm in
the UV-vis absorption spectrum of the CuII-bipyOXA complex was used to monitor the
interaction with DNA.
However, such band is absent in ZnII-bipyOXA and very weak in NiII-bipyOXA (see
Figure 3.8a). As a consequence, only the interaction of DNA with [Cu(bipyOXA)2(H2O)2]2+
has been thoroughly investigated.
The pyOXA ligand and its NiII, CuII and ZnII complexes are sparingly soluble in wa-
ter solution, possibly as a consequence of the perchlorate coordination (see Figure 3.5b),
that makes difficult to obtain a dicationic complex in solution, as observed for the bypy-
OXA complexes (see Figure 3.5a). In Figure 3.8b the UV-vis spectra of the ligand pyOXA
and of its metal complexes in CH3CN are reported. Here, it is even more evident the
absence in all the compounds examined of a convenient band in a region where DNA
does not absorb (AbsmaxDNA = 258 nm), that could be used to monitor the interaction with
DNA through a spectrophotometric titration with the biologic polymer. These two con-
ditions prevented the investigation of the interaction between DNA and the NiII, CuII
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Figure 3.8: (a) Uv-vis spectra in 1 mM Tris-HCl buffer of bipyOXA (10 µM, —) and its 30 µM CuII
(- - -), NiII (· · · ) and ZnII (- · -) complexes; (b) Uv-vis spectra in CH3CN of the ligand bipyOXA
(10 µM, —) and its 10 µM CuII (- - -), NiII (· · · ) and ZnII (- · -) complexes.
and ZnII complexes of the pyOXA ligand.
3.3.1 UV-visible
[Cu(bipyOXA)2(H2O)2]2+ complex presents two strong absorption bands at 230 and 275
nm, attributable to the ligand, and a characteristic d−d band at 340 nm. The absorbances
at 340 and 275 nm follow the Lambert-Beer law in the concentration range 22 - 180 µM.
The DNA-[Cu(bipyOXA)2(H2O)2]2+ interaction was studied by monitoring the spectral
variations of the absorption band at 340 nm upon addition of increasing amounts of
DNA to solutions of [Cu(bipyOXA)2(H2O)2]2+ (Figure 3.9).
The observed hypochromism (see Figure 3.9) with increasing DNA concentration,
up to 47% at [DNA]/[complex] = 7.0, the absence of a red shift of the monitored band
and the values of the intrinsic binding constant Kb suggests the groove binding and
electrostatic binding nature of the complex to DNA in preference over an intercalative
mode of binding [158, 159, 180].
The data have been analyzed by the following equation (inset in Figure 3.9):
[DNA]
2("a − "f )
=
[DNA]
2("b − "f )
+
1
Kb("b − "f)
(3.1)
where "a is the ratio between the measured absorbance and the molar concentration of
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Figure 3.9: Uv-vis of the compound [Cu(bipyOXA)2(H2O)2]2+ ([complex] = 110 µM , 1 mM Tris-
HCl buffer) in the presence of increasing concentration of ct-DNA, in the range [DNA]:[complex]
shown in the legend. Inset: plot of [DNA]/(#a − #f ) vs. [DNA] from eqn. 3.1.
[Cu(bipyOXA)2(H2O)2]2+, "f is the molar extinction coefficient for the free metal com-
plex and "b is the molar extinction coefficient for the metal complex bound to DNA [66,
181, 182].
Plotting [DNA]/("a− "f ) vs. [DNA], Kb is given by the ratio of slope to the intercept.
The DNA-[Cu(bipyOXA)2(H2O)2]2+ binding constant Kb is equal to 2.2 × 104 M−1 and
is comparable to that of DNA- groove binders [158,159]. Indeed, the size of the cationic
copper complex [Cu(bipyOXA)2(H2O)2]2+ is comparable to that of typical DNA groove
binders [4]. The observed hypochromism with increasing DNA concentration, up to
47% at [DNA]:[complex] = 7.0, is also in agreement with an electrostatic groove binding
nature of the complex to DNA [158, 159].
3.3.2 DNA Thermal Denaturation Analysis
The thermal denaturation profiles of native DNA in the presence of increasing amounts
of [Cu(bipyOXA)2(H2O)2]2+, obtained by plotting the UV absorbance at 258 nm as a
function of temperature, are reported in Figure 3.10.
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Figure 3.10: Thermal denaturation profiles of ct-DNA solutions (100 µM ct-DNA, 1.0 mM
Tris-HCl) in the presence of increasing amounts of [Cu(bipyOXA)2(H2O)2]2+, in the range
[DNA]:[complex] shown in the legend. ct-DNA, Tm= 58.5 ± 0.1; 5:1 Tm= 64.0 ± 0.1; 2:1, Tm=
65.3 ± 0.1 ◦C.
At [DNA]:[complex] molar ratios 5:1 and 2:1, the DNA melting temperature in-
creases of 5.5 and 6.5 ◦C, respectively, confirming that the double helical structure is only
slightly perturbed by the interaction with the complex. Considering that intercalative
mode of binding to DNA normally gives significantly high positive ∆Tm values [183],
these results suggest electrostatic and/or groove binding nature of the [Cu(bipyOXA)2-
(H2O)2]2+ complex, a result in agreement with the UV-vis titration (see Figure 3.9).
3.3.3 Circular Dichroism
The CD spectrum of B-DNA is characterized by a positive band centered at 275 nm,
a negative band at 240 nm (black solid line in Figures 3.11a). Figure 3.11 shows that
these bands are only weakly modified by the addition of increasing amounts of the
complex [Cu(bipyOXA)2(H2O)2]2+, showing that the double helical structure is only
slightly perturbed by the interaction with the metal complex. Nevertheless, the presence
of an induced CD band in the range 300-375 nm (i.e around the UV absorption band
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Figure 3.11: CD of 100 µM ct-DNA (1 mM Tris-HCl buffer) in the presence of increasing concen-
tration of the complex [Cu(bipyOXA)2(H2O)2]2+, in the range [DNA]:[complex] shown in the
legend.
of the metal complex, see Figure 3.9) points out that [Cu(bipyOXA)2(H2O)2]2+ tightly
binds to the chiral scaffold of the DNA double helix, acting as a new CD chromophore.
Such evidence, in agreement with the value of the binding constant obtained by the
spectrophotometric titration shown in Figure 3.9, can be interpreted by hypothesizing
the existence of an electrostatic binding between the cationic metal complex and the
negatively charged phosphate groups of DNA, in which [Cu(bipyOXA)2(H2O)2]2+ is a
groove binder.
3.3.4 Gel electrophoresis
The characteristic agarose gel pattern of plasmid DNA consists generally in two bands,
one intense corresponding to the negatively-supercoiled DNA and another one to the
open-circle DNA.
Figure 3.12 shows the agarose gel electrophoresis pattern of pBR322 DNA (lane 1)
treated with [Cu(bipyOXA)2(H2O)2]2+ at [DNA]:[complex] molar ratios equal to 2:1 and
1:1 (lane 2 and 3, respectively). The results obtained allowed to establish that, in the
experimental conditions used, [Cu(bipyOXA)2(H2O)2]2+ does not degrade the DNA or
even affect its mobility.
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Figure 3.12: Agarose gel electrophoresis pattern of pBR322 DNA (lane 1) in the presence of
[Cu(bipyOXA)2(H2O)2]2+ at different [DNA]:[complex] ratios: lane 2, 2:1; lane 3, 1:1
3.3.5 Viscosity
It is known that molecules that are able to intercalate DNA induce an unwinding of
the duplex supercoils, giving rise to an increase of DNA viscosity and a decrease of the
density of DNA, thus a decrease in the rate of migration through agarose gel [80, 184].
DNA viscosity experiments in the presence of [Cu(bipyOXA)2(H2O)2]2+ confirm the
absence of DNA-intercalation and reinforce the conclusion that it is a groove binder.
In fact, the relative viscosity of 100 µM DNA in Tris-HCl 1 mM, is not affected by the
presence of the complex, at the molar ratio values [DNA]:[complex] equal to 2:1, 1.25:1
and 1:1. The average value of relative viscosity, (η/η0)1/3 , where η0 is the viscosity of
the DNA solution alone, was 0.999 ± 0.001.
3.4 Cytotoxic Tests
The cytotoxicity of [Cu(bipyOXA)2(H2O)2]2+ and of bipyOXA, as control, on HepG2
and HT29 cells was evaluated by means of MTT cell viability/proliferation assay, as
reported in Materials and Methods (see Section 3.6). While bipyOXA was not cyto-
toxic, inhibition of cell proliferation by the copper complex [Cu(bipyOXA)2(H2O)2]2+
was already evident (10%) at 8 h of treatment at 5 µM concentration and reached its
maximum (85-90%) at 48 h of treatment at 40 µM concentration. The cytotoxicity was
similar on both the cell lines as confirmed by the concentrations that kill and/or inhibit
cell growth by 50% (IC50) calculated at 24 h of treatment (Figure 3.13a).
Trypan blue was used to count viable cells with comparable results to those obtained
by MTT test. Dramatic cell morphological changes were observed by light microscopy.
3.5. Conclusions 89
a
b
bipyOXA
[Cu(bipyOXA)2(H2O)2](ClO4)2
Figure 3.13: (a) Concentration- and time-dependent effect of bipyOXA and
[Cu(bipyOXA)2(H2O)2]2+ on HepG2 and HT29 cell viability. (b) Cell morphological ana-
lysis at 24 h of treatment (magnification 40X). (C) Flow cytometric analysis of cell cycle
distribution at 24 h of treatment.
Cells became rounded, detached from culture substrates and floated in the medium,
indicating the commitment to apoptotic death (Figure 3.13b). This conclusion is also
supported by flow cytometric analysis. Cytometric profiles of the propidium iodide-
stained DNA showed that treatment of HepG2 and HT29 cells for 24 h with 40 µM
of the copper complex [Cu(bipyOXA)2(H2O)2]2+ resulted in DNA fragmentation for
a significant amount of cells, 55.5 and 48.5% respectively, confined in the sub-G0/G1
phase of cell cycle (Figure 3.13C). This result was considered as an index of apoptosis.
3.5 Conclusions
The novel copper complexes [M(bipyOXA)2(H2O)2]ClO4)2 and [M(pyOXA)2ClO4)2] (M
= CuII, ZnII and NiII), were synthesized and structurally characterized in the solid state
and in solution. The study of the interaction of [Cu(bipyOXA)2(H2O)](ClO4)2 with nat-
ive DNA , through circular dichroism, variable temperature UV-visible absorption, gel
electrophoresis and viscosity, was reported.
Cellular uptake experiments showed that, despite the inactivity of bipyOXA ligand,
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its CuII complex reduces the vitality of human hepatoblastoma and colorectal carcinoma
cells lines, in a dose- and time-dependent manner. The results of the biological assays
receive a positive feedback in the DNA binding studies performed. The spectroscopic
and hydrodynamic investigations showed that the copper(II) complex has the charac-
teristics of a DNA groove binder, displaying good affinity while preserving the native
B-DNA form.
This work represents the first study of the biological activity of a copper(II) com-
plex of 1,2,4-oxadiazole ligands. Infact, despite the bioactivity of analogous platinum
complexes, so far only a few metal complexes of 1,2,4-oxadiazole ligands have been
considered for biological studies.
3.6 Experimental
3.6.1 Materials and Method
All chemicals and solvents were purchased from Sigma–Aldrich, Fisher or Alfa Aesar
and used as received, without further purification.
Proton and carbon nuclear magnetic resonance spectra were recorded on Bruker
AC300 spectrometer, solvent residual peaks were used as reference. Flash chromato-
graphy was performed by using silica gel (Merck, 0.040-0.063 mm) and mixtures of
ethyl acetate and petroleum ether (fraction boiling in the range of 40-60 ◦C) in various
ratios.
Mass spectrometry (MS) and MS/MS measurements of the complexes have been car-
ried out by using electrospray ionization (ESI) with a LCQ-DECA ion trap (Thermo, Bre-
men, Germany). Operating conditions of the ESI source were as follows: spray voltage
4.5 kV ; capillary temperature 200 ◦C; sheath gas (nitrogen) flow rate, ca. 0.75 L min−1.
Ultra-pure helium was the collision gas. CID collision energy: 0.5-1.0 eV (laboratory
frame). A methanol solution of the complex (1 × 10−4 M) was introduced into the mass
spectrometer using a syringe pump at a flow rate of 5 µL min−1.
Melting points were determined on a Reichart-Thermovar hot stage apparatus and
are uncorrected. IR spectra were registered with a Shimadzu FTIR-8300 instrument.
Viscosity measurements were performed on a Ubbelodhe viscosimeter maintained
at 25.0 ± 0.1 ◦C. Flow time was measured with a digital stopwatch.
Ultrapure water (18.2 MΩ, Fisher) was used in all UV-vis, circular and linear dichro-
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ism experiments and for electrophoresis gel. Lyophilized calf thymus DNA, purchased
from Sigma-Aldrich, was resuspended in Tris-HCl (pH 7.5) and dialyzed as described
in the literature [144]. The DNA concentration was determined by UV-vis measure-
ments using the molar extinction coefficient of "260 = 7000 mol−1 dm3 cm−1 per DNA
base [135–138].
Spectroscopic studies
Absorption measurements were performed on a Varian Cary 5000 UV-vis double beam
spectrophotometer or on a Varian UV–vis Cary 1E double beam spectrophotometer,
both equipped with a Peltier temperature controller, using 1 cm pathlength cuvettes.
Circular dichroism spectra were recorded at 25 ◦C on a Jasco J-715 spectropolari-
meter, using 1 cm path–length quartz cells.
X-ray crystallography
A Bruker-Nonius FR591 rotating anode diffractometer with graphite monochromated
Mo-Ka radiation (λ = 0.71073 A˚) was used for data collection at 120(2) K. The structure
was solved by direct methods implemented in the SHELXS-97 program. The refinement
was carried out by full-matrix anisotropic least-squares on F2 for all reflections for non-
H atoms by using the SHELXL- 97 program [148, 149].
The complex [Cu(bipyOXA)2(H2O)2]ClO4)2 crystallizes in the triclinic crystal sys-
tem, and in the P1¯ space group. Four molecules constitute the asymmetric unit. A
statistical disorder has been found for the N(1) and O(2) atoms of each oxadiazole ring
and for a perchlorate anion.
Gel electrophoresis
Gel electrophoresis experiments of pBR322 DNA (0.5 mg mL−1, Fermentas) were per-
formed in a 2% agarose gel, through an electrophoresis system with the following para-
meters: voltage, 100 V; electric current, 250 mA; time, 1.5 h. TAE buffer 1X (obtained
by dilution of 50X TAE, pH 8.0, SIGMA) was used as working buffer. In detail, 17 mL
volume samples loaded in the gel contained a fixed concentration of pBR322 DNA (0.06
µg mL−1) and increasing concentration of [Cu(bipyOXA)2(H2O)2]ClO4)2 . Once incub-
ated for 1.5 h at 37 ◦C, to each sample 5 mL of loading buffer (Blue/Orange Loading
Dye, 6X, 0.4% orange G, 0.03% bromophenol blue, 0.03% xylene cyanol FF, 15% Ficoll
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400, 10 mM Tris-HCl, pH 7.5 and 50 mM EDTA, pH 8.0, Promega Madison USA) were
added. The gel was revealed with ethidium bromide (0.5 µg mL−1 ) and was finally
visualized using a UV lamp.
Cytotoxic Test
Human hepatoblastoma HepG2 and colorectal carcinoma HT29 cells were grown as
monolayers in RPMI 1640 medium, supplemented with 10% (v/v) heat-inactivated fetal
calf serum (FCS) and 2.0 mM glutamine, in a humidified atmosphere of 95% air and 5%
CO2 at 37 ◦C. HepG2 culture medium also contained 1.0 mM sodium pyruvate.
HepG2 and HT29 cells (1 × 104) were grown in 200 µL medium in 96-well plate
overnight. The cells were treated with [Cu(bipyOXA)2(H2O)2]2+ (2.5-40 µM) or with
bipyOXA (40 µM), dissolved in 1 mM Tris-HCl buffer pH 7.4, for 8, 24 and 48 h. The
cytotoxic effect was determined by MTT cell viability/proliferation test. Control samples
were treated with vehicle only. MTT data (average of four independent experiments in
triplicate) are expressed as percent of untreated control cells [185]. IC50 values were
calculated at 24 h of treatment. Morphological changes were observed by means of
light microscopy (magnification 40X). Colorimetric quantification was determined by
an ELISA microplate reader at 570 nm (test WL) and 630 nm (reference WL), using lysis
buffer as a blank. After treatment, cells (1 × 106) were harvested by trypsinization and
incubated for 2-3 h at 4 ◦C in a hypotonic solution containing 50 µg mL−1 propidium
iodide, 0.1% sodium citrate, 0.01% Nonidet P-40 and 10 µg mL−1 RNase A. After stain-
ing, cells were subjected to flow cytometric analysis of DNA content using a Beckman
Coulter Epics XL cytometer. The percentage of cells in the different phases of the cycle
was calculated using Expo32 software. Cell debris and aggregates were excluded by
opportune gating and 5000 events/sample were analyzed.
3.6.2 Synthesis and characterization
bipyOXA ligand and its CuII, ZnII and NiII complexes
3,5-bis(2’-pyridyl)-1,2,4-oxadiazole (bipyOXA): 1.00 g of 2-cyanopyridine (4) (8.14 mmol)
and 0.56 g of 2- picolinamidoxime (5) [186] (4.07 mmol) were mixed in a sealed tube and
heated at 120 ◦C for 8 h. The residue was chromatographed yielding 0.59 g of 3,5-bis(2’-
pyridyl)-1,2,4-oxadiazole (65%): mp 173-176 ◦C (from EtOH) (lit. 173-175 ◦C) [187] ;
1H NMR (300 MHz, CDCl3) δ (ppm): 7.44 - 7.58 (m, 2H); 7.87 - 7.98 (m, 2H); 8.28 - 8.31
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(d, 1H); 8.42 - 8.44 (d, 1H); 8.84 - 8.89 (m, 2H).
1H NMR (300 MHz, CD3CN) δ (ppm): 8.96 - 8.70 (m, 2H), 8.34 (dt, J = 7.9, 1.0 Hz, 1H),
8.21 (dt, J = 7.9, 1.1 Hz, 1H), 8.13 - 7.91 (dtd, J = 17.3, 7.8, 1.8 Hz, 2H), 7.64 (ddd, J = 7.7,
4.8, 1.2 Hz, 1H), 7.56 (ddd, J = 7.7, 4.8, 1.2 Hz, 1H).
13C NMR (75 MHz, CD3CN) δ (ppm): 176.1 (C), 170.0 (C), 151.5 (CH), 151.3 (CH), 147.3
(C), 144.5 (C), 138.7 (CH), 138.4 (CH), 128.1 (CH), 126.9 (CH), 125.3 (CH), 124.4 (CH).
UV (MeOH): " = 1.7 × 104 (λ = 274 nm); " = 1.5 × 104 (λ = 231 nm) cm−1M−1. UV (Tris-
HCl, pH = 7.5): 1.5 × 104 (λ = 275 nm); " = 1.7 × 104 (λ = 231 nm) cm−1M−1
[Cu(bipyOXA)2(H2O)2]2+(ClO4)2: A light blue solution of Cu(ClO4)2 · 6H2O (0.09 g,
0.24 mmol) in absolute ethanol was added drop wise and under constant stirring to a
colorless solution of 3,5-bis(2’-pyridyl)-1,2,4-oxadiazole (0.11 g, 0.50 mmol) in absolute
ethanol and at room temperature. The mixture was let under stirring for 12 h, the pre-
cipitate filtered, washed with cold absolute ethanol and dried under vacuum (0.152 g;
85%). The solid was recrystallized from acetonitrile. After one week at 4 ◦C, blue crys-
tals of [Cu(bipyOXA)2](ClO4)2 · 2H2O, suitable for X-ray crystallographic analysis, were
obtained.
MS-ESI (m/z): 609.73 ([Cu(bipyOXA)2]ClO
+
4 ).
Elemental analysis calcd (%) for CuC24H20N8O12Cl2 : C, 38.59, H, 2.70, N, 15.00; found:
C, 38.51, H, 2.69, N, 15.13. UV (Tris-HCl 1mM, pH = 7.5): " = 4.2 × 103 (λ = 340 nm); " =
3.3 × 104 (λ = 273 nm); " = 3.8 × 104 (λ = 231 nm) cm−1M−1
IR (Nujol) ν (cm−1) :1651 m, 1616 m, 1560 s, 1257 m, 1116 s, 1047 s, 1009 m, 923w, 807w,
756m, 624s.
[Zn(bipyOXA)2(H2O)2]2+(ClO4)2: A solution of Zn(ClO4)2 · 6H2O (0.14 g, 0.4 mmol) in
absolute ethanol was added dropwise and under constant stirring to a colorless solu-
tion of 3,5-bis(2’-pyridyl)-1,2,4-oxadiazole (0.179 g, 0.8 mmol) in absolute ethanol and
at room temperature. The mixture was let under stirring for 12 h in the dark, the white
precipitate filtered, washed with cold absolute ethanol and dried under vacuum (0.215
g; 72%). The solid was recrystallized from acetonitrile.
MS-ESI (m/z): 610.87 ([Zn(bipyOXA)2]ClO
+
4 ); 386.93 ([Zn(bipyOXA)]ClO
+
4 ).
Elemental analysis calcd (%) for ZnC24H20N8O12Cl2 : C, 38.50, H, 2.69, N, 14.97; found:
C, 38.31, H, 2.63, N, 15.06. UV (Tris-HCl 1mM, pH = 7.5): " = 3.9 × 104 (λ = 273 nm); " =
4.2 × 104 (λ = 231 nm) cm−1M−1
1H NMR (300 MHz, CD3CN) δ (ppm): 8.69 - 8.37 (m, 4H), 8.31 (t, J = 7.8 Hz, 1H), 8.18 (t,
J = 7.8 Hz, 1H), 7.89 - 7.68 (m, 2H).
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13C NMR (75 MHz, CD3CN) δ (ppm): 176.3 (C), 166.5 (C), 150.9 (CH), 150.0 (CH), 142.5
(CH), 142.1 (C), 140.8 (C), 140.6 (CH), 130.3 (CH), 130.0 (CH), 127.2 (CH), 125.1 (CH).
[Ni(bipyOXA)2(H2O)2]2+(ClO4)2: A light green solution of Ni(ClO4)2 · 6H2O (0.15 g,
0.4 mmol) in absolute ethanol was added drop wise and under constant stirring to a
colorless solution of 3,5-bis(2’-pyridyl)-1,2,4-oxadiazole (0.179 g, 0.80 mmol) in absolute
ethanol and at room temperature. The mixture was let under stirring for 12 h in the
dark, the precipitate filtered, washed with cold absolute ethanol and dried under va-
cuum (0.244 g; 83%). The solid was recrystallized from acetonitrile.
MS-ESI (m/z): 604.93 ([Ni(bipyOXA)2]ClO
+
4 ); 380.9 ([Ni(bipyOXA)]ClO
+
4 ).
Elemental analysis calcd (%) for NiC24H20N8O12Cl2 : C, 38.85, H, 2.72, N, 15.10; found:
C, 38.67, H, 2.68, N, 15.07. UV (Tris-HCl 1mM, pH = 7.5): " = 1.0 × 103 (λ = 340 nm); " =
3.9 × 104 (λ = 275 nm); " = 4.4 × 104 (λ = 231 nm) cm−1M−1
pyOXA ligand and its CuII, ZnII and NiII complexes
3-(2’-pyridyl)5-(phenyl)-1,2,4-oxadiazole (pyOXA): 1 g of 2- picolinamidoxime (5) [186]
(7.3 mmol) and 1.12 g of benzoyl chloride (9, 8.03 mmol, d=1.2 g/mL) were mixed in
120 mL of toluene. 0.64 mL of pyridine (0.63 g, 8.03 mmol, d=0.98 g/mL) was added
and the mixture was left refluxing for 12 h. The residue was chromatographed yielding
0.60 g of 3-(2’-pyridyl)5-(phenyl)-1,2,4-oxadiazole (70%) [188].
1H NMR (300 MHz, CD3CN) δ (ppm): 8.77 (dd, J = 11.8, 7.8 Hz, 1H), 8.30 - 8.15 (m, 3H),
8.04 - 7.91 (m, 1H), 7.76 - 7.59 (m, 3H), 7.59 - 7.49 (m, 1H).
13C NMR (75 MHz, CD3CN) δ (ppm): 177.1 (C), 169.8 (C), 151.3 (CH), 147.4 (C), 138.3
(CH), 134.1 (CH), 130.4 (CH), 128.9 (CH), 126.8 (CH), 125.1 (C), 124.3 (CH).
UV (CH3CN): " = 2.1 × 104 (λ = 259 nm); " = 1.8 × 104 (λ = 234 nm) cm−1M−1.
Cu(pyOXA)2(ClO4)2: a light blue solution of Cu(ClO4)2 · 6H2O (0.15 g, 0.4 mmol) in
absolute ethanol was added drop wise and under constant stirring to a colorless solu-
tion of pyOXA (0.178 g, 0.8 mmol) in absolute ethanol and at room temperature. The
mixture was let under stirring for 12 h, the precipitate filtered, washed with cold abso-
lute ethanol and dried under vacuum (0.230 g; 81%). The solid was recrystallized from
acetonitrile. After one week at 4 ◦C, blue crystals of Cu(pyOXA)2(ClO4)2 suitable for
X-ray crystallographic analysis, were obtained.
MS-ESI (m/z): 607.8 ([Cu(pyOXA)2ClO4]+); 385 ([Cu(pyOXA)ClO4]+).
Elemental analysis calcd (%) for CuC26H18N6O10Cl2 : C, 44.05, H, 2.56, N, 11.85; found:
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C, 44.19, H, 2.35, N, 11.83. UV (CH3CN): " = 4.0 × 104 (λ = 259 nm); " = 4.2 × 104 (λ =
234 nm) cm−1M−1.
Zn(pyOXA)2(ClO4)2: a solution of Zn(ClO4)2 · 6H2O (0.149 g, 0.4 mmol) in absolute eth-
anol was added drop wise and under constant stirring to a colorless solution of pyOXA
(0.179 g, 0.8 mmol) in absolute ethanol and at room temperature. The mixture was let
under stirring for 12 h in the dark but no precipitate was observed. The solution was
let for 6 h at -18 ◦C the precipitate was filtered, washed with cold absolute ethanol and
dried under vacuum (0.20 g; 70%). The solid was recrystallized from acetonitrile.
MS-ESI (m/z): 608.87 ([Zn(pyOXA)2ClO4]+); 386.13 ([Zn(pyOXA)ClO4]+).
Elemental analysis calcd (%) for ZnC26H18N6O10Cl2 : C, 43.94, H, 2.55, N, 11.82; found:
C, 42.48, H, 2.32, N, 11.37. UV (CH3CN): " = 4.4 × 104 (λ = 259 nm); " = 3.9 × 104 (λ =
236 nm) cm−1M−1.
1H NMR (300 MHz, CD3CN) δ (ppm): 9.02 (d, J = 5.23 Hz, 1H), 8.47 - 8.25 (dd, J = 4.46,
8.32 Hz, 2H), 8.14 - 7.93 (dd, J = 4.91, 9.41 Hz, 1H), 7.88 - 7.60 (m, 3H), 7.49 (t, J = 7.80,
7.80 Hz, 2H).
13C NMR (75 MHz, CD3CN) δ (ppm): 178.7 (C), 165.3 (C), 150.2 (CH), 143.3 (CH), 141.6
(C), 135.1 (CH), 130.3 (CH), 130.1 (CH), 129.5 (CH), 124.8 (CH), 121.2 (C).
Ni(pyOXA)2(ClO4)2: A light green solution of Ni(ClO4)2 · 6H2O (0.15 g, 0.4 mmol) in
absolute ethanol was added drop wise and under constant stirring to a colorless solu-
tion of pyOXA (0.179 g, 0.80 mmol) in absolute ethanol and at room temperature. The
mixture was let under stirring for 12 h in the dark but no precipitate was observed. The
solution was let for 6 h at -18 ◦C the precipitate was filtered, washed with cold absolute
ethanol and dried under vacuum (0.210 g; 75%). The solid was recrystallized from acet-
onitrile.
MS-ESI (m/z): 602.9 ([Ni(pyOXA)2ClO4]+); 379.9 ([Ni(pyOXA)ClO4]+).
Elemental analysis calcd (%) for NiC26H18N6O10Cl2 : C, 44.35, H, 2.58, N, 11.94; found:
C, 44.05, H, 3.04, N, 11.22. UV (CH3CN): " = 4.3 × 104 (λ = 259 nm); " = 4.0 × 104 (λ =
236 nm) cm−1M−1.
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Words are flying out like endless rain
into a paper cup, they slither while
they pass, they slip away across the
universe
Lennon/McCartney, 1969
4.1 Introduction
Deoxyribonucleic acid is the biomolecule that preserves the genetic information ofmost organisms and, for this reason, was identified as one of the principal tar-
gets for anticancer compounds. Synthetic molecules able to bind DNA have attracted
a great interest in the last 50 years. The research was mostly focused on non-covalent
recognition of DNA by small molecules, with particular emphasis for the intercalation
mechanism [2] (see Introduction, Section 1.2). In recent years, the synthesis of metallo-
supramolecular assemblies has prompted the research of alternative systems with a
different chemical nature and different effects on the biologic polymer. For example,
tetracationic supramolecular cylinders, which bind strongly and non-covalently in the
major groove, cause remarkable intramolecular coiling of DNA [2, 78, 189].
Furthermore and more interestingly, these kind of molecules are able to recognize
Figure 4.1: Three-dimensional structure of a tetracationic supramolecular cylinder inserted in a
3-way junction DNA [40]
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a specific unusual DNA structure called three-way junction (see Figure 4.1), opening
the possibility to overcome drug-resistance problems encountered with classical and
nonspecific drugs with broad cytotoxic effects [40]. In this context, the self-assembly-
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Figure 4.2: Fujita’s platinum square
mediated synthesis of metallamacrocycles, such as molecular squares and rectangles, is
a growing area at the forefront of supramolecular chemistry [190–195]. In particular, the
combination of pyridyl ligands with PdII or PtII complexes has become a powerful tool
to synthesize 2d and 3d suprastructures [190, 193, 196, 197]. These architectures display
interesting applications in various fields, especially as host-guest chemistry [190, 198].
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Figure 4.3: Structure of [DAzP]NO3 and [Pt2(DAzP)2(en)2](NO3)6.
Recently, the self-assembled platinum molecular square extensively explored by the
group of Fujita (see Figure 4.2) was found to bind ct-DNA, G-quadruplex DNA and to
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inhibit telomerase [198–200]. Apart from the above mentioned studies, up to now, no
DNA binding studies and cytotoxic tests are reported for this kind of molecules.
Prompted by these considerations, the DNA binding properties and the cytotoxicity
of 2,7-diazapyrenium- based ligand and its PtII metallacycle (compounds [DAzP]NO3
and [Pt2(DAzP)2(en)2](NO3)6 respectively, see Figure 4.3) were investigated.
4.2 Structural characterization
The aromatic nucleophilic substitution of 4-chloro-1,3-dinitrobenzene with 2,7-diazapy-
rene produced the activated intermediate N-(2,4-dinitrophenyl)-2,7-diazapyrenium salt
(13 in the Figure 4.4, see Section 4.6).
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Figure 4.4: Reaction scheme for [DAzP]NO3 and [Pt2(DAzP)2(en)2](NO3)6 (see text for details).
For the preparation of [DAzP]NO3 the Zincke reaction was used [201] being, up to
now, the first example of this kind of reaction with a 2,7-diazapyrene derivative. The
exchange of the 2,4-dinitroaniline moiety 13 by 4-(pyridin-4-ylmethyl)aniline (14) gave
[DAzP]PF6. This last step takes presumably advantage of an addition of the nucleophile,
ring opening and ring closing (ANRORC) mechanism. The nitrate salt was prepared by
metathesis of [DAzP]PF6 with tetrabutylammonium nitrate (TBAN). [DAzP]PF6 was
characterized by ESI-HRMS mass spectrometry and 2D-NMR, including COSY, HSQC
and HMBC spectra (see Experimental, Section 2.5 and Appendix A). The same NMR
measurements were performed for [DAzP]NO3.
The metallacycle was synthetized by the reaction of [DAzP]NO3 with Pt(en)(NO3)2
in H2O for 8 days at 100 ◦C. The Pt-N coordination bond inertness at low temperat-
ure is lost when the temperature is increased. This dual feature has been exploited by
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Figure 4.5: 1H-NMR (D2O, 500 MHz) of [DAzP]NO3 (above) and [Pt2(DAzP)2(en)2](NO3)6 (bot-
tom).
Fujita to introduce the ”molecular lock” concept [39]. Obviously, the reaction time and
temperature were chosen to assure the thermodynamic control over the self-assembly.
[Pt2(DAzP)2(en)2](PF6)6 was characterized by ESI-HRMS mass experiments and 2d-NMR,
including COSY, HSQC and HMBC spectra (see Experimental, Section 2.5 and Ap-
pendix A). The same NMR experiments were performed for [Pt2(DAzP)2(en)2](NO3)6.
Mass spectrometry showed peaks resulting from the loss of between two and five hex-
afluorophosphate anions. As concerns the NMR (Figure 4.5), the downfield shift of
protons H1 and H9 and the upfield shift of H2, H4, H5 and H6 clearly suggested the
complexation of DAzP ligand to the metal center and the formation of the rectangle (Fig-
ure 4.3). The presence of other cyclic structures was discarded by dilution experiments
monitored by 1H NMR spectroscopy.
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4.2.1 X-ray crystallography
The structure of [DAzP]PF6 was confirmed by means of X-ray crystallography of suit-
able single crystals obtained by vapor diffusion of diethyl ether into a CH3CN solution
of a monoprotonated form of the ligand. The dihedral angle between the planes defined
by the phenylene and diazapyrene systems is 52◦(Figure 4.6).
a b
Figure 4.6: Crystal structures of (a) [DAzP]PF6 and (b) the inclusion complex of the pyrene with
the metallacycle [Pt2(DAzP)2(en)2](PF6)6. Solvent molecules and counterions have been omitted
for clarity. The color labelling scheme is as follows: carbon (dark grey), nitrogen (blue), fluorine
(green), phosphorus (orange) and platinum (purple).
It was not possible to crystallize the metallacycle alone, but a crystal structure of its
inclusion complex with a pyrene molecule was obtained. As a matter of fact, these rect-
angular metallacycles have proven to be receptors for polycyclic aromatic hydrocarbons
(PAHs), such as pyrene, phenanthrene, triphenylene, and benzo[a]pyrene [202]. Their
cavities present a nearly optimal size to form supramolecular complexes with PAHs
through pi-stacking and hydrophobic forces.
The formation of the 1:1 inclusion complexes in the solid state was confirmed by
X-ray crystallography analysis of single crystals obtained by vapor diffusion of isopro-
pyl ether into CH3CN solutions of the pyrene and [Pt2(DAzP)2(en)2](PF6)6 (Figure 4.6).
The distance between the planes defined by the guest and the diazapirenium moieties
is very close to the optimal separation maximizing pi-pi interactions. The metallacycle
length and width are about 14.90 and 7.0 A˚, respectively. The planes defined by the
diazapyrene systems are parallel to each other and nearly perpendicular to the equat-
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orial plane of the metallacycle defined by their four corners.
4.3 DNA interaction studies
In order to compare changes in the optical properties of DNA upon binding to the
compounds [DAzP]NO3 and [Pt2(DAzP)2(en)2](NO3)6, titration experiments were per-
formed using different spectroscopic techniques. Moreover the ability of these com-
pounds to change the mobility of DNA in a electrophoretic experiment was evaluated
as well as their capacity to inhibit the DNA amplification in a PCR assay.
4.3.1 Circular and linear dichroism
The CD spectrum of DNA in its native B-form is characterized by a positive band
centered at 275 nm, a negative band at 240 nm, with the zero being around 258 nm
(black solid line in Figures 4.7a and 4.8a). In the same way, B-DNA exhibits a character-
istic LD spectrum with a typical negative band between 220 nm and 300 nm (black solid
line in Figures 4.7b and 4.8b), caused by pi-pi∗ transitions [70]. Spectral changes of these
bands and, above all, the presence of induced bands (ICD and ILD) in others regions of
the spectrum, provide a convenient tool for monitoring the interaction between the two
compounds and the biopolymer.
In Figure 4.7 the CD (a) and LD (b) spectra of ct-DNA in the presence of increasing
amounts of the [DAzP]NO3, up to [DNA]/[DAzP] molar ratios of approximately 2:1,
are shown. The titration was carried out adding increasing amounts of DAzP stock
solutions to a ct-DNA solution with constant concentration. To ensure that, during the
titration, the concentration of the DNA remained unaltered, for each addition of DAzP
the same volume of a double-concentrated DNA solution was added. All the samples
for which CD and LD spectrum was collected contained a fixed concentration of NaCl
(10 mM) and sodium cacodylate buffer (1 mM).
The CD data obtained, with the presence of two ICD bands at approximately 320
and 420 nm separated by an isodichroic point at 378 nm, clearly demonstrate that DAzP
binds the biological polymer acting as a further chromophore appended to the chiral
backbone of the DNA double helix [70]. The DNA band centred at 240 nm is monoton-
ously increased by the addition of the ligand probably as a consequence of an induced
absorption by the ligand itself in that region. Nevertheless, the B-form of the polymer
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Figure 4.7: (a) CD of 100 µM ct-DNA and (b) LD of 300 µM ct-DNA, in 10 mM NaCl and 1
mM cacodylate buffer in the presence of increasing concentration of [DAzP]NO3, in the range
[DNA]:[DAzP] shown in the legend.
is preserved, as confirmed by the unmodified positive DNA band at 240 nm. The LD
spectra in Figure 4.7b confirm the CD data indicating that the ligand is oriented in a
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specific way by the polynucleotide. The presence of the two negative ILD bands (in the
same region of the ICD bands) and the fact that the compound induces an enhancement
of the DNA negative band clearly indicate an intercalative binding mode, as expected
from the planar molecular geometry.
Changes in CD and LD spectra of DNA upon addition of [Pt2(DAzP)2(en)2](NO3)6
are presented in Figure 4.8a and 4.8b respectively. The binuclear square complex has a
strong effect on the DNA structure and presents a completely different behaviour with
respect to DAzP. The modifications in the CD region between 200-300 nm are similar
to those seen for [DAzP]NO3 (Figure 4.7a) but, at the same molar ratios, the effect is
stronger for the metallacycle. The ICD bands in the region 300-475 nm present a big
intensity and in particular the one centred at 350 nm reaches almost the same intens-
ity of the DNA negative band. In the LD spectra shown in Figure 4.8b it is possible
to recognize the induced LD bands in the same positions seen in the CD spectra but
both negative. Interestingly, the characteristic LD signal of DNA in the presence of the
metallacycle decreases dramatically even at very small mixing ratios. This latter finding
is consistent with bending/coiling of the DNA by [Pt2(DAzP)2(en)2](NO3)6. As recently
reported for iron and ruthenium supramolecular cylinders [78, 189], the metallacyle in-
duces the extent of DNA orientation in the experiment. The compaction of DNA due
to the metallacycle presence is also confirmed by the precipitation occurring at molar
ratios smaller than 8:1.
The binding constant of the [DAzP]NO3-DNA system was determined by a method
recently reported in the literature and using the following equation [203]:
y = 0.5R[A+B + x−
√
(A+B + x)2 − 4Bx] (4.1)
where A, B and R are fitting parameters, the binding constant is Kb = 1/A, while B =
BT/n (where BT is the total number of nitrogen bases and n the number of bases per
binding site) and R represents the instrumental response sensitivity [203]). Fitting eqn 4.1
to CD and LD experimental data at 431 nm (see Figure 4.9) through a Levenberg-Mar-
quardt least squares routine we obtain the Kb values for the ligand-DNA binding, equal
to (3.6 ± 2) × 105 M−1 and (5.3 ± 0.5) × 105 M−1, respectively. The good agreement of
the constant value using two different spectroscopic techniques indicates the reliability
of the data. The precipitation phenomenon during the metallacycle-DNA titration did
not allow to calculate a binding constant for [Pt2(DAzP)2(en)2](NO3)6 with the same set
of experiments.
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Figure 4.8: (a) CD of 150 µM ct-DNA and (b) LD of 150 µM ct-DNA, in 10 mM NaCl and 1 mM
cacodylate buffer in the presence of increasing concentration of [Pt2(DAzP)2(en)2](NO3)6, in the
range [DNA]:[metallacycle] shown in the legend.
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Figure 4.9: Titration data of DAzP derived by taking a vertical cross section at 431 nm in Fig-
ure 4.7a for CD and Figure 4.7b for LD experiment. The solid line is the theoretical fit of the data
using eqn 4.1. In both graphs epsilon = y.
4.3.2 Fluorescence
In fluorescence spectroscopy investigations, of particular interest are molecules that can
reversibly switch from a non-emissive to an emissive state [16].
Water solutions of compounds [DAzP]NO3 and [Pt2(DAzP)2(en)2](NO3)6 share an
emission band at 439 nm when excited at 290 nm. DAzP is stable under irradiation
and has a stronger emission with respect to the metallacycle. Furthermore, UV-vis ex-
periments confirmed that the PtII complex is slightly light sensible. Binding of both
compounds with the DNA helix was found to strongly quench the dyes fluorescence.
Figure 4.10: Effect of increasing concentration of ct-DNA on the luminescence of DAzP. Vial 1:
DAzP 120 µM, Vials 2-6: [DNA]/[DAzP] 0.5:1; 1:1; 1.5:1; 2:1; 2.5:1.
In particular, water solutions of DAzP are luminescent when illuminated with a UV
lamp (λexc = 312 nm) and a strong quenching is observed when DNA is added (see Fig-
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ure 4.10). For these reasons fluorescence spectroscopy was used to further investigate
the interaction between the two compounds and DNA.
Figure 4.11: Fluorescence titration of 20 µM DAzP, in 10 mM NaCl and 1 mM cacodylate buffer
in the presence of increasing concentration of ct-DNA, in the range [DNA]:[DAzP] shown in the
legend. Inset: Scatchard plot of the fluorescence titration data at 439 nm using eqn 4.2.
Titration experiments were carried out by adding increasing amounts of DNA to a 20
µM solutions of the [DAzP]NO3 ligand and of the PtII metallacycle. The decrease of the
DAzP fluorescence due to the addition of DNA is presented in Figure 4.11. The spectral
changes arise from changes in the environment of the fluorophore upon intercalating
DNA.
Figure 4.12 shows the fluorimetric titration of the metallacycle with increasing amount
of DNA. The trend is the same as seen in Figure 4.11 for DAzP, but the relatively poor
emission of the complex and its light sensitivity prevented the possibility to obtain re-
producible and accurate data to calculate the binding constant.
To obtain the value of the intercalation constant for the DAzP-DNA system from the
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Figure 4.12: Fluorescence titration of 20 µM metallacycle, in 10 mM NaCl and 1 mM cacodylate
buffer in the presence of increasing concentration of ct-DNA, in the range [DNA]:[metallacycle]
shown in the legend.
fluorimetric titration the following equation was used [204–207]:
r
Cf
= Ki(1− nr)
{
1− nr
1− (n− 1)r
}n−1
(4.2)
where r is the ratio between the concentration of the bound ligand (Cb) and the DNA,Ki
is the intrinsic binding constant and n is the exclusion parameter in base pairs. Cb values
were obtained subtracting Cf (the concentration of free ligand) to the total concentration
of the ligand (Ct). Cf was determined according to the following equation [208, 209]:
Cf = Ct
( II0 − P )
(1− P )
(4.3)
where I0 and I are the fluorescence intensities of the ligand in the absence and in pres-
ence of DNA, respectively. P = Ilim/I0 was obtained from the minimum value of I (Ilim)
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at high DNA concentration and the initial value of I0 in the absence of DNA.
In the inset of Figure 4.11 a Scatchard plot was constructed from r/Cf vs. r and the
best fit of the data has returned a value of Ki equal to (5.6 ± 0.5) × 105 M−1. This last
value is in very good agreement with the ones obtained by CD and LD experiments.
4.3.3 Ethidium bromide displacement assays
Figure 4.13: Displacement of ethidium bromide (10 µM) from ct-DNA (30 µM) by increasing
concentration of (a) DAzP and (b) [Pt2(DAzP)2(en)2](NO3)6, in the range [DNA]:[drug] shown
in the legend.
In order to calculate the binding constant of the interaction between the metalla-
cycle and the DNA, ethidium bromide (EB) fluorescence displacement assays were per-
formed. It is well known that the intrinsic fluorescence intensity of DNA water solu-
tions is very low. In the same way, EB water solutions present a very weak fluorescence
that is enhanced by the addition of DNA because of its intercalation. The fluorescence
intensity of EB intercalated into DNA can be quenched by the addition of another mo-
lecule due to decreasing of the binding sites of DNA available for EB. The titrations of
the EB-DNA system with DAzP and the metallacycle are shown in Figure 4.13a and b,
respectively. In both cases there is a fluorescence decrease. However, the effect of the
metallacycle is stronger. Probably, while in the case of DAzP, that is an intercalator, there
is only a replacement effect, the coiling produced by [Pt2(DAzP)2(en)2](NO3)6 does not
allow the EB to occupy most of the DNA binding sites. The apparent binding constant
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for both compounds was calculated from:
KEB[EB] = Kapp[drug50%] (4.4)
where [drug50%] is the concentration of DAzP or of the metallacycle at 50% reduction of
fluorescence and KEB is the binding constant for the ethidium bromide [210]. Using a
value of ≈ 1.2 × 106 M−1 for KEB [211, 212], the following binding constants were ob-
tained: (4.1± 0.5)× 105 M−1 for DAzP and (6.8± 0.5)× 106 M−1 for [Pt2(DAzP)2(en)2](NO3)6.
4.3.4 DNA Thermal Denaturation Analysis
Thermal denaturation profiles of calf thymus DNA solutions, in the presence of increas-
ing amounts of compounds [DAzP]NO3 and [Pt2(DAzP)2(en)2](NO3)6 , are shown in
Figures 4.14a and b respectively. DNA-melting experiments were carried out by mon-
itoring the absorbance of DNA (258 nm) at various temperatures in the absence and
presence of the compounds at differents [DNA]:[drug] ratios. The temperature was el-
evated gradually from 20 to 95 ◦C at a rate of 0.5 ◦C per min.
Figure 4.14: Thermal denaturation profiles of ct-DNA solutions (100 µM ct-DNA, 1.0 mM Tris-
HCl, 20 mM NaCl) in the presence of increasing amounts of , (a) DAzP (ct-DNA, Tm= 59.7 ± 0.1;
10:1 Tm= 80.0 ± 0.1; 3:1, Tm= 89.0 ± 0.1; 1.5:1, Tm= 91.8 ± 0.2; 1:1, Tm= 92.3 ± 0.2 ◦C) and (b)
metallacycle (ct-DNA, Tm= 60.2 ± 0.1; 20:1 Tm= 61.3 ± 0.2; 14:1, Tm= 70.6 ± 0.2; 10:1, Tm= 75.8 ±
0.3 ◦C
When the temperature is increased the double stranded DNA gradually dissociates
into single strands. The DNA melting temperature (Tm) is defined as the temperature
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where half of the total base pairs are unpaired and is obtained from a sigmoidal fit of the
experimental data [67]. The ability of [DAzP]NO3 to alter the thermal denaturation pro-
file of DNA in a stronger way with respect to the metallacycle [Pt2(DAzP)2(en)2](NO3)6
is another indication of the differences in the DNA binding mode. In fact, it is known
that the intercalation of natural or synthesized compounds results in a strong stabiliza-
tion of the double helix due to stacking interactions, thus in a considerable increase in
the melting temperature of DNA [67–69]. The effect of DAzP results in an increase of
the DNA melting temperature (59.7 ± 0.1 ◦C) of 20 ◦C at the ratio [DNA]/[DAzP] equal
to 10:1. At the same ratio value, the PtII complex increases the DNA Tm of about 15 ◦C.
Although the binding of [Pt2(DAzP)2(en)2](NO3)6 to DNA is very strong, as seen
with other techniques, the general loss of planarity compared with [DAzP]NO3 alone
causes a smaller stabilization of the double strand. In the same way as for the CD and
LD experiments, it was impossible to reach lower [DNA]:[metallacycle] ratios due to
precipitation.
4.3.5 Gel electrophoresis
Plasmid Gel Electrophoresis. A gel electrophoresis experiment was performed in or-
der to see how the gel mobility of negatively supercoiled plasmid is affected by the
compounds [DAzP]NO3 and [Pt2(DAzP)2(en)2](NO3)6.
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Figure 4.15: Agarose gel electrophoresis patterns for unwinding of supercoiled pBR322 plasmid
DNA by (a) DAzP and (b) [Pt2(DAzP)2(en)2](NO3)6. In each gel the top bands correspond to
the circular plasmid form while the bottom bands to the supercoiled one. Lane C: DNA control;
Lanes 1-6: [DNA]/[drugs] 20:1; 12:1; 8:1; 6:1; 5:1; 3:1.
The characteristic agarose gel pattern of plasmid DNA consists generally in two
bands, one intense corresponding to the negatively-supercoiled DNA (lower band in
Figure 4.15 a and b lane C) and another one to the open-circle DNA. It is well known
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that molecules that are able to bind DNA could induce an unwinding of the duplex su-
percoils resulting in a decrease in the rate of migration through agarose gel [80, 81]. As
shown in Figure 4.15 a and b, with the increase of the drug concentration (lanes 1-6), the
intensity of the supercoiled DNA band decreases only when the metallacycle is added,
while, in this experimental condition, DAzP has no effect.
PCR Gel Electrophoresis. As LD experiments showed [Pt2(DAzP)2(en)2](NO3)6 coils
dramatically DNA. To investigate whether this effect could prevent the replication of
DNA, polymerase chain reaction (PCR) assays were performed. PCR is a straightfor-
ward technique which amplifies a double strand DNA mimicking in vitro the cellular
replication process [85, 213, 214] (see Section 2.2.7).
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Figure 4.16: PCR inhibition assay with [Pt2(DAzP)2(en)2](NO3)6 and DAzP at increasing con-
centration. L) 100 bp oligonucleotide ladders; 1) control (0 µM); 2) 0.05 µM; 3) 0.1 µM; 4) 0.3 µM;
5) 0.5 µM; 6) 1 µM.
It comprises three simple steps, repeated cyclically, required for any DNA synthesis
reaction: (1) denaturation of the template, (2) annealing of primers to each original
strand for new strand synthesis and (3) extension of the new DNA strands from the
primers by a thermostable polymerase [85, 86]. In this PCR assay plasmidic pUC19
DNA was incubated with increasing concentration of both metallacycle and its DAzP
ligand for 5 minutes at room temperature, then amplified. Agarose gel electrophoresis
of the reaction products after 35 cycles, followed by ethidium bromide staining and UV
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visualization, showed a single DNA product of the expected length (Figure 4.16).
Interestingly, the metallacycle is able to block completely the amplification of DNA
even at 0.1 µM concentration. On the other hand DAzP does not affect at all the PCR.
This result confirm that the binding of the metallacycle to DNA can prevent the regular
activity of the polymerase and makes this compound a possible candidate as anticancer
drug.
4.4 Cytotoxic Tests
The spectroscopic studies indicate the existence of a strong interaction between DNA
and both DAzP and [Pt2(DAzP)2(en)2](NO3)6, even if the mode of binding is different
in the two cases. Gel electrophoresis studies and, above all, PCR experiments emphasize
the potential role of [Pt2(DAzP)2(en)2](NO3)6 as anticancer drug. In order to verify the
biological activity of the two compounds, cytotoxic tests against different human cancer
cell lines were performed (see Matherials and Methods, Section 4.6).
The IC50 values for the compound [Pt2(DAzP)2(en)2](NO3)6 are presented in Table 4.1
and a range between 3.1 - 19.2 µM can be noticed. The anti-proliferative activities of the
metallacycle is relatively selective in the 5 human cancer cell line, with the A-427 line
being the most sensitive and the SISO line being the least. Interestingly, SISO is very
sensitive to cisplatin but not to this compound. Likewise, of the 5 cell lines, A-427 is
the least sensitive to cisplatin but the most sensitive to the metallacycle. Noteworthy is
the observation that in the A-427 cell line [Pt2(DAzP)2(en)2](NO3)6 has potency nearly
as good as cisplatin. By contrast [DAzP]NO3 was inactive.
Table 4.1: IC50 (µM) values of the analyzed compounds. Results are averages of three inde-
pendent determinations with standard deviations.
Cell Line Metallacycle Cisplatin
SISO 19.24 ± 7.13 0.24 ± 0.05
DAN-G 11.76 0.53 ± 0.07
A-427 3.12 ± 1.22 1.27 ± 0.25
LCLC-103H 9.47 ± 3.12 1.09 ± 0.40
5637 7.61 ± 6.65 0.37 ± 0.08
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4.5 Conclusions
The interaction with native DNA of a 2,7-diazapyrenium-based ligand and its PtII rect-
angular metallacycle was studied by means of different spectroscopic techniques. Qual-
itative and quantitative information was achieved. In particular, DAzP ligand was
found to be an intercalator with a binding constant approximately equal to 5.0 × 105
M−1, while the metallacycle produces a coiling of the biologic polymer with a binding
constant of 7.0 × 106 M−1.
Confirming the spectroscopic results, gel electrophoresis experiments highlight the
stronger effect of the metallacycle on the DNA with respect to DAzP. [Pt2(DAzP)2(en)2](NO3)6
is able to reduce the DNA electrophoretic mobility and, more interestingly, inhibits the
DNA amplification (PCR assay) suggesting a possible use as anticancer drug.
As a matter of fact, the metallacycle resulted active towards 5 human cancer cell
lines, with an activity comparable to that of cisplatin in one cell line.
4.6 Experimental
4.6.1 Materials and Method
All chemicals and solvents were purchased from Sigma–Aldrich, Fisher or Alfa Aesar
and used as received. Deuterated solvents for NMR were supplied by Cambridge Iso-
tope Laboratories, Inc. and Goss scientific.
Proton and carbon nuclear magnetic resonance spectra were recorded on a Bruker
Avance 300 or Bruker Avance 500 equipped with a dual cryoprobe for 1H and 13C, using
the residual protonated solvent as internal standard.
Mass spectrometry experiments were carried out in a LC-Q-q-TOF Applied Biosys-
tems QSTAR Elite spectrometer for low- and high-resolution ESI.
Ultrapure water (18.2 MΩ, Fisher) was used in all UV-vis, circular and linear dichro-
ism experiments and for electrophoresis gel. Lyophilized calf thymus DNA, purchased
from Sigma-Aldrich, was resuspended in sodium cacodylate buffer (Na(CH2)2AsO2 ·
3H2O, pH 6.8 - 7.4) and dialyzed as described in the literature [144]. The DNA concen-
tration was determined by UV-vis measurements using the molar extinction coefficient
of "260 = 7000 mol−1 dm3 cm−1 per DNA base [135–138].
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Spectroscopic studies
Stock solutions of 1 M NaCl, 1 M Tris-HCl and 100 mM sodium cacodylate buffer were
prepared and, together with DNA stock, were used to obtain the final work solutions.
Absorption measurements were performed on a Varian Cary 5000 UV-vis double
beam spectrophotometer or on a Varian UV-vis Cary 1E double beam spectrophoto-
meter, both equipped with a Peltier temperature controller, using 1 cm pathlength cu-
vettes.
Circular dichroism spectra were collected using a Jasco J-810 spectropolarimeter in
cuvettes of pathlength 1 cm. The following parameters were used: sensitivity, 100 mdeg;
wavelength range, 200 -750 nm; data pitch, 0.5 nm; scanning mode, continuous; scan-
ning speed, 200 nm min−1; response, 0.1 s; bandwidth, 1.0; accumulation, 12. Linear
dichroism spectra were collected using a Jasco J-810 spectropolarimeter. In particular, it
was adapted for LD measurements with a flow Couette cell, ideal to give an orientation
to long molecules such DNA [145]. The following parameters were used: sensitivity, 100
mdeg; wavelength range, 200-750 nm; data pitch, 0.5 nm; scanning mode, continuous;
scanning speed, 500 nm min−1; response, 0.25 s; bandwidth, 2.0; accumulation, 8.
The fluorescence spectra were recorded in a Shimadzu RF-5301 PC Fluorescence
Spectrophotometer. DAzP, (λexc = 290 nm; range emission = 300-700 nm; resolution
= 0.4 nm; speed = medium; excitation slit = 1.5; emission slit = 3; sensitivity = high).
metallacycle, (λexc = 290 nm; Range emission = 300-700 nm; resolution = 0.4 nm; speed
= medium; excitation slit = 1.5; emission slit = 5; sensitivity = high). All over the
titration, the concentration of the DAzP/[Pt2(DAzP)2(en)2](NO3)6 was kept constant
while increasing amounts of DNA were added. All samples contained a fixed con-
centration of NaCl (10 mM) and sodium cacodylate buffer (1 mM). Luminescence was
visualized using a UVtec-uvipro platinum system. EB displacement assay: DAzP and
[Pt2(DAzP)2(en)2](NO3)6, (λexc = 500 nm; Range emission = 520-800 nm; resolution = 0.4
nm; speed = medium; excitation slit = 5; emission slit = 5; sensitivity = high). In this
experiment the concentrations of DNA and EB were kept constants while increasing
amounts of DAzP/[Pt2(DAzP)2(en)2](NO3)6 were added. All samples contained a fixed
concentration of NaCl (10 mM) and sodium cacodylate buffer (1 mM).
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Gel electrophoresis
The electrophoresis experiments were performed through Electrophoresis Power Sup-
ply (EPS 301) system with the following parameters: voltage, 120 V; ampere, 190 mA;
time, 2.5 h. Gel trays of 210 × 150 mm with a 15-toothed comb were used. In all of the
electrophoresis experiments 1X Tris acetate (obtained by dilution of 10X TAE, supplied
by SIGMA) was used as working buffer. In detail, the gel was prepared warming up
2 g of agarose (from USB corporation) in 200 mL of 1X TAE. pBR322 plasmide DNA
(1mg/mL, New England Biolabs) was used to prepare the samples. The images of the
gels were visualized and acquired using a UVtec-uvipro platinum system.
As concerns the PCR gel electrophoresis experiment, twelve reaction mixtures were
prepared, all containing 1X NH4 reaction buffer, MgCl2 (1.5 mM), pUC19 plasmid DNA
substrate (50 ng, Sigma Aldrich), Taq DNA polymerase (5U; Bioline), dNTPs (3 mM),
the primers (0.4 µM each) pUC19F (5’-CGGTGAAAACCTCTGACACA -3’) and M13
reverse (5’-CAGGAAACAGCTATGACC -3’; Alta Bioscience). The images of the gels
were visualized and acquired using a UVtec-uvipro platinum system.
Cytotoxic Test
All stock solutions were prepared in DMSO and stored at -30 ◦C. Prior to testing stock
solutions were removed from the freezer and serially diluted in DMSO 2-fold to the
desired concentrations, giving the series of five dilutions. To investigate the cytotoxic
potency of the compounds 5 different human cancer cell lines were used. SISO a cervical
cancer cell line, 5637 from bladder cancer, A-427 and LCLC-103H a lung cancer cell
lines and DAN-G a pancreas carcinoma cell line (see Table 4.2). All human cancer cell
lines were obtained from the German Collection of Microorganisms and Cell Cultures
(DSMZ, Braunschweig).
Cells were grown in medium containing 90% RPMI 1640 medium (Sigma, Taufe-
nkirchen, Germany) and 10% FCS (Sigma), supplemented with penicillin G/strepto-
mycin. Cells were kept at 37 ◦C in a water saturated atmosphere of 5% CO2 air. Shortly
before the cells reached confluence the cells were passaged.
Screening methods. The cells were seeded out in 96-well microtiter plates in 100 µl
medium at a density of 1000 cells/well (LCLC-103H 250 cells/well). The plates were re-
turned to the incubator for 24 h. The next day the stock solutions and the dilutions were
directly diluted in medium 500-fold. 100 µl of the medium containing the compounds
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Table 4.2: Human cancer cell lines used in the cytotoxic assay.
Cell Line Patient (sex, age) Origin Doubling Time (h)
SISO F, 67 Cervix adenocarcinoma 48
DAN-G – Pancreas carcinoma 42
A-427 M, 52 Lung carcinoma 38
LCLC-103H M, 61 Large cell lung cancer 40
5637 M, 68 Urinary bladder carcinoma 30
were added to each well with a maximum DMSO concentration of 0.1% (v/v). After the
complete incubation period of 96 h the medium was discarded and replaced for 25 min
with a 1% glutaraldehyde buffer (PBS) solution to fix the cells. The fixing buffer was
discarded and the cells were stored under PBS at 4 ◦C until staining. Staining was done
with a 0.02% solution of Crystal Violet in water. The dye was added to each well and
discarded after 30 min of staining, followed by 15 min washing with water. The cell-
bound dye was redissolved in 70% ethanol/water. Optical density was measured at λ
= 570 nm with an Anthos 2010 plate reader (Anthos, Salzburg, Austria). The corrected
T/C values for the dose-response curves were calculated:
T
Ccorr
=
(ODtest −ODt=0)
(ODcon − ODt=0)
× 100 (4.5)
where ODtest is the mean optical density of the treated cells after staining, ODcon is
the mean optical density of the controls and ODt=0 is the mean optical density at the
time the compounds were added. The IC50 values were calculated by a linear least-
squares regression of the T/Ccorr values versus the logarithm of the added compound
concentration and extrapolating to the T/Ccorr values of 50%.
X-ray crystallography
The structures were solved by direct methods and refined with the full-matrix least-
squares procedure (SHELX-97)[28] against F 2. The X-ray diffraction data were collected
on a Bruker X8 ApexII diffractometer. Non-solvent hydrogen atoms were placed in
idealized positions with Ueg(H) = 1.2 Ueg(C) and were allowed to ride on their parent
atoms. Solvent hydrogen atoms were placed in idealized positions with Ueg(H) = 1.5
Ueg(C) and were allowed to ride on their parent atoms.
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4.6.2 Synthesis and characterization
Compounds 13, 14 (see Figure 4.4) and 2,7-diazapyrene were prepared according to
published procedures [215–218].
[DAzP]PF6, 15a: a solution of 2-(2,4-dinitrobenzyl)-2,7-diazapiren-2-ium chloride
(13·Cl) (1.03 g, 2.77 mmol) and 4-(pyridin-4-ylmethyl)aniline (14) (2.04 g, 11.07 mmol) in
EtOH (75 mL) was refluxed for 3d, after cooling, the solvent was evaporated in vacuo.
The resulting residue was dissolved in H2O (200 mL) and extracted with EtOAc (200
mL). The organic layer was further extracted with H2O (2×150 mL) and the combined
aqueous extracts were washed with EtOAc (4×75 mL). The solvent was removed under
reduced pressure to give a crude product, which was purified by column chromato-
graphy (SiO2, acetone/NH4Cl 1.5M/MeOH 5:4:1). The product-containing fractions
were combined and the solvents were removed in vacuo. The residue was dissolved in
H2O/CH3OH (95:5, 250 mL) and an excess of KPF6 was added until no further precip-
itation was observed. The solid was filtered and washed with water to give [DAzP]PF6
(0.97 g, 70%) as a dark yellow solid. Vapor diffusion of ethyl ether into a CH3CN solu-
tion gave dark yellow crystals good for X-ray analysis.
1H NMR (500 MHz, CD3NO2) δ (ppm): 4.68 (s, 2H), 7.84 (d, J = 8.6 Hz, 2H), 8.08 (d, J =
8.6 Hz, 2H), 8.11 (d, J = 6.7 Hz, 2H), 8.69 (d, J = 9.1 Hz, 2H), 8.82 (d, J = 6.8 Hz, 2H), 8.84
(d, J=9.1Hz, 2H), 9.91 (s, 2H), 9.92 (s, 2H).
13C NMR (125 MHz, CD3NO2) δ (ppm): 42.1 (CH2), 125.5 (C), 127.2 (CH), 127.3 (CH),
127.6 (C), 129.3 (CH), 130.4 (C), 130.6 (C), 133.1 (CH), 133.2 (CH), 139.3 (CH), 142.5 (CH),
142.7 (C), 144.8 (C), 149.9 (CH).
MS-ESI (m/z): 372.2 [M - PF−6 ]
+; elemental analysis calcd (%) for C26H18F6N3P: C, 60.35,
H, 3.51, N, 8.12; found: C, 60.08, H, 3.86, N, 8.33.
[DAzP]NO3, 15b: [DAzP]PF6 (500.0 mg, 0.97 mmol) was dissolved in the minimum
amount of CH3CN and an excess of Bu4NNO3 was added until no further precipitation
was observed. The white precipitate was filtered and washed with CH3CN to yield
[DAzP]NO3 (356.0 mg, 85%) as a brown solid.
1H NMR (500 MHz, D2O) δ (ppm): 4.56 (s, 2H), 7.77 (d, J = 8.5 Hz, 2H,), 7.98 (m, 4H),
8.46 (d, J = 9.1 Hz, 2H), 8.56 (d, J = 9.1 Hz, 2H), 8.70 (d, J = 6.8 Hz, 2H), 9.57 (s, 2H), 9.95
(s, 2H).
13C NMR (125 MHz, D2O) δ (ppm): 40.5 (CH2), 123.9 (C), 125.5 (CH), 126.1 (CH), 126.2
(C), 127.3 (CH), 128.0 (C), 128.7 (C),131.0 (CH), 131.6 (CH), 138.2 (CH), 141.1 (C), 141.2
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(CH), 142.6 (C), 146.8 (CH), 161.5 (C).
MS-ESI (m/z): 372.2 [M - NO3]+; elemental analysis calcd (%) for C26H18N4O3: C, 71.88,
H, 4.18, N, 12.90; found: C, 71.60, H, 3.88, N, 13.20.
[Pt2(DAzP)2(en)2](PF6)6, 16a: A solution of [DAzP]NO3 (120.0 mg, 0.276 mmol) and
(en)Pt(NO3)2 (104.7 mg, 0.276 mmol) in H2O (60 mL) was heated at 100 ◦C for 8d. Upon
cooling to room temperature, an excess of KPF6 was added until no further precipitation
was observed. The solid was filtered to yield [Pt2(DAzP)2(en)2](PF6)6 (281.7 mg, 96%)
as a brown solid.
1H NMR (500 MHz, CD3NO2) δ (ppm): 3.19 (m, 8H), 4.26 (s, 4H), 7.42 (d, J = 8.6 Hz,
4H), 7.51 (d, J = 6.8 Hz, 4H), 7.63 (d, J = 8.7 Hz, 4H), 8.63 (d, J = 9.2 Hz, 4H), 8.67 (d, J =
9.2 Hz, 4H), 8.82 (d, J = 6.8 Hz, 4H), 9.69 (s, 4H), 10.00 (s, 4H).
13C NMR (125 MHz, CD3NO2) δ (ppm): 41.1 (CH2), 49.8 (CH2), 49.9 (CH2), 126.2 (C),
126.3 (CH), 128.9 (C), 129.5 (CH), 130.0 (CH), 130.4 (C), 130.7 (C), 131.6 (CH), 132.3 (CH),
140.5 (CH), 143.6 (C), 144.7 (C) 151.1 (CH), 153.6 (CH), 156.7 (C).
HRMS-ESI (m/z): calcd for [M - 2PF−6 ]
2+ 917.1114; found 917.1085; calcd for [M - 3PF−6 ]
3+
563.0860; found 563.0853; calcd for [M - 4PF−6 ]
4+ 386.0733; found 386.0749; calcd for [M -
5PF−6 ]
5+ 279.8657; found 279.8671. Elemental analysis calcd (%) for C56H52F36N10P6Pt2:
C, 31.65, H, 2.47, N, 6.59; found: C, 31.84, H, 2.19, N, 6.33.
[Pt2(DAzP)2(en)2](NO3)6, 16b: [Pt2(DAzP)2(en)2](PF6)6 (95.0 mg, 0.0445 mmol) was dis-
solved in the minimum amount of CH3CN and an excess of Bu4NNO3 was added until
no further precipitation was observed. The white precipitate was filtered and washed
with CH3CN to yield [Pt2(DAzP)2(en)2](NO3)6 (72.5 mg, 99%) as a brown solid.
1H NMR (500 MHz, D2O) δ (ppm): 2.93 (m, 8H), 4.16 (s, 4H), 7.39 (d, J = 8.6 Hz, 4H),
7.48 (m, 8H), 8.50 (d, J = 9.2 Hz, 4H), 8.57 (d, J = 9.2 Hz, 4H), 8.78 (d, J = 6.8 Hz, 4H), 9.70
(s, 4H), 9.95 (s, 4H).
13C NMR (125 MHz, D2O) δ (ppm): 39.8 (CH2), 47.6 (CH2), 47.6 (CH2), 124.8 (CH), 125.0
(C), 127.3 (C), 127.7 (CH), 128.1 (CH), 128.8 (C), 129.0 (C), 129.7 (CH), 130.6 (CH), 139.0
(CH), 141.8 (C), 142.7 (C) 149.0 (CH), 151.6 (CH), 155.1 (C).
Elemental analysis calcd (%) for C56H52N16O18Pt2: C, 41.33, H, 3.22, N, 13.77; found: C,
41.56, H, 3.08, N, 13.67.
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NMR spectra
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Figure A.1: 1H NMR (500 MHz, DMSO) spectrum of the compound NiL2+
126 A. NMR spectra
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Figure A.2: 13C NMR and DEPT (125 MHz, DMSO) spectra of the compound NiL2+
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Figure A.3: COSY (500 MHz, DMSO) spectrum of the compound NiL2+
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Figure A.4: HSQC (500 MHz, DMSO) spectrum of the compound NiL2+
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Figure A.5: HMBC (500 MHz, DMSO) spectrum of the compound NiL2+
128 A. NMR spectra
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Figure A.6: 1H NMR (500 MHz, DMSO) spectrum of the compound ZnL2+
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Figure A.7: 13C NMR and DEPT (125 MHz, DMSO) spectra of the compound ZnL2+
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Figure A.8: COSY (500 MHz, DMSO) spectrum of the compound ZnL2+
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Figure A.9: HSQC (500 MHz, DMSO) spectrum of the compound ZnL2+
130 A. NMR spectra
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Figure A.10: HMBC (500 MHz, DMSO) spectrum of the compound ZnL2+
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Figure A.11: 1H NMR (500 MHz, D2O) spectrum of the compound ZnL2+
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Figure A.12: DEPT 13C NMR (125 MHz, D2O) spectra of the compound ZnL2+
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Figure A.13: COSY (500 MHz, D2O) spectrum of the compound ZnL2+
132 A. NMR spectra
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Figure A.14: HSQC (500 MHz, D2O) spectrum of the compound ZnL2+
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Figure A.15: HMBC (500 MHz, D2O) spectrum of the compound ZnL2+
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Figure A.16: 1H NMR (300 MHz, CD3CN) spectrum of the compound bipyOXA
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Figure A.17: 13C NMR (75 MHz, CD3CN) spectrum of the compound bipyOXA
134 A. NMR spectra
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Figure A.18: COSY (300 MHz, CD3CN) spectrum of the compound bipyOXA
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Figure A.19: 1H NMR (300 MHz, CD3CN) spectrum of the Zn2 complex with bipyOXA
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Figure A.20: 13C NMR (75 MHz, CD3CN) spectrum of the Zn2 complex with bipyOXA
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Figure A.21: 1H NMR (300 MHz, CD3CN) spectrum of the compound pyOXA
136 A. NMR spectra
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Figure A.22: 13C NMR (75 MHz, CD3CN) spectrum of the compound pyOXA
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Figure A.23: 1H NMR (300 MHz, CD3CN) spectrum of the Zn2 complex with pyOXA
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Figure A.24: 13C NMR (75 MHz, CD3CN) spectrum of the Zn2 complex with pyOXA
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Figure A.25: COSY (300 MHz, CD3CN) spectrum of the Zn2 complex with pyOXA
138 A. NMR spectra
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Figure A.26: 1H NMR (500 MHz, CD3NO2) spectrum of the compound [DAzP]PF6
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Figure A.27: 13C NMR (125 MHz, CD3NO2) spectrum of the compound [DAzP]PF6
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Figure A.28: COSY (500 MHz, CD3NO2) spectrum of the compound [DAzP]PF6
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Figure A.29: HSQC (500 MHz, CD3NO2) spectrum of the compound [DAzP]PF6
140 A. NMR spectra
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Figure A.30: HMBC (500 MHz, CD3NO2) spectrum of the compound [DAzP]PF6
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Figure A.31: 1H NMR (500 MHz, D2O) spectrum of the compound [DAzP]NO3
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Figure A.32: 13C NMR (125 MHz, D2O) spectrum of the compound [DAzP]NO3
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Figure A.33: COSY (500 MHz, D2O) spectrum of the compound [DAzP]NO3
142 A. NMR spectra
!#$$#$##$)"$)"#!"$!"#$#$$##(#$(##)$#$)$#$
!$
#$
)$
!$
$$
($
)$$
))$
)&$
)*$
)!$
)#$
"
"
!
"
Figure A.34: HSQC (500 MHz, D2O) spectrum of the compound [DAzP]NO3
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Figure A.35: HMBC (500 MHz, D2O) spectrum of the compound [DAzP]NO3
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Figure A.36: 1H NMR (500 MHz, CD3NO2) spectrum of the compound [Pt2(DAzP)2(en)2](PF6)6
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Figure A.37: 13C NMR (125 MHz, CD3NO2) spectrum of the compound [Pt2(DAzP)2(en)2](PF6)6
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Figure A.38: COSY (500 MHz, CD3NO2) spectrum of the compound [Pt2(DAzP)2(en)2](PF6)6
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Figure A.39: HSQC (500 MHz, CD3NO2) spectrum of the compound [Pt2(DAzP)2(en)2](PF6)6
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Figure A.40: HMBC (500 MHz, CD3NO2) spectrum of the compound [Pt2(DAzP)2(en)2](PF6)6
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Figure A.41: 1H NMR (500 MHz, D2O) spectrum of the compound [Pt2(DAzP)2(en)2](NO3)6
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Figure A.42: 13C NMR (125 MHz, D2O) spectrum of the compound [Pt2(DAzP)2(en)2](NO3)6
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Figure A.43: COSY (500 MHz, D2O) spectrum of the compound [Pt2(DAzP)2(en)2](NO3)6
!"#$#!$#$&#!&#$$#!$#$'#!'#$(#!(#$)#!)#$*#!*#$(!#$
!!
$!
&!
$!
'!
(!
)!
*!
(!!
((!
(!!
($!
(&!
(#!
('!
"!"
#
#
$
#
#
#
$
#
%& #!"
%&
#!
#!
!
!
Figure A.44: HSQC (500 MHz, D2O) spectrum of the compound [Pt2(DAzP)2(en)2](NO3)6
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Figure A.45: HMBC (500 MHz, D2O) spectrum of the compound [Pt2(DAzP)2(en)2](NO3)6

Appendix B
X-Ray crystallographic data
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Figure B.1: Ortep view of the second of the two crystallographically independent copper com-
plexes of CuL2+ with ellipsoids drawn at the 50 % probability level. Three methyl groups,
C(124)/C(24’), C(126)/C(26’) and C(128)/C(28’) are disordered over two positions each. The
perchlorate ions, benzene, nitromethane and water molecules and hydrogen atoms have been
omitted for clarity.
Figure B.2: The two crystallographically independent copper complexes of CuL2+ form columns
in the (1 0 0) direction through intermolecular pi-pi stacking interactions with an interplanar dis-
tance of approximately 3.3 A˚. The minor components of the disordered methyl groups, perchlor-
ate ions, benzene, nitromethane and water molecules and hydrogen atoms have been omitted
for clarity. Carbon atoms are coloured grey, nitrogen atoms blue, oxygen atoms red and copper
atoms orange.
Figure B.3: View of the four crystallographically independent molecules of [Cu(bipyOXA)2-
(H2O)2]2+ constituting the asymmetric unit. Ellipsoids enclose 50% probability.The color la-
belling scheme is as follows: carbon (dark grey), nitrogen (blue), chlorine (green), copper (or-
ange) and oxygen (red).
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